DENTSPLY SIRONA (XRAY) 10-Q 30 Jul 15 2015 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Jul. 21, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	DENTSPLY INTERNATIONAL INC /DE/
Entity Central Index Key	818,479
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Trading Symbol	XRAY
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Common Stock, Shares Outstanding		139,808,237

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Income Statement [Abstract]
Net sales	$ 698,006	$ 765,225	$ 1,354,326	$ 1,495,339
Cost of products sold	298,345	340,756	581,297	676,665
Gross profit	399,661	424,469	773,029	818,674
Selling, general and administrative expenses	274,979	296,121	545,212	583,963
Restructuring and other costs	38,881	1,242	44,307	2,035
Operating income	85,801	127,106	183,510	232,676
Other income and expenses:
Interest expense	9,824	11,798	20,492	22,753
Interest income	(660)	(1,744)	(1,402)	(3,179)
Other expense (income), net	(376)	575	232	963
Income before income taxes	77,013	116,477	164,188	212,139
Provision for income taxes	24,775	26,096	43,628	48,548
Equity in net loss of unconsolidated affiliated company	(8,174)	(367)	(12,541)	(657)
Net income	44,064	90,014	108,019	162,934
Less: Net (loss) income attributable to noncontrolling interests	(35)	21	(42)	63
Net income attributable to DENTSPLY International	$ 44,099	$ 89,993	$ 108,061	$ 162,871
Earnings per common share:
Basic	$ 0.32	$ 0.63	$ 0.77	$ 1.15
Diluted	$ 0.31	$ 0.62	$ 0.76	$ 1.13
Weighted average common shares outstanding:
Basic	139,813	141,790	140,054	141,921
Diluted	142,262	144,164	142,521	144,288

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Statement of Comprehensive Income [Abstract]
Net income	$ 44,064	$ 90,014	$ 108,019	$ 162,934
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	75,972	(27,640)	(112,932)	(28,675)
Net (loss) gain on derivative financial instruments	(16,824)	440	7,928	2,197
Net unrealized holding gain (loss) on available-for-sale securities	39,416	(1,762)	70,267	(3,803)
Pension liability adjustments	(8)	823	1,409	1,141
Total other comprehensive income (loss), net of tax	98,556	(28,139)	(33,328)	(29,140)
Total comprehensive income	142,620	61,875	74,691	133,794
Less: Comprehensive income attributable to noncontrolling interests	(40)	(254)	500	(140)
Net (decrease) increase in other comprehensive income	$ 142,660	$ 62,129	$ 74,191	$ 133,934

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Current Assets:
Cash and cash equivalents	$ 96,472	$ 151,639
Accounts and notes receivables-trade, net	447,500	426,606
Inventories, net	374,820	387,095
Prepaid expenses and other current assets, net	351,538	241,630
Total Current Assets	1,270,330	1,206,970
Property, plant and equipment, net	568,036	588,845
Identifiable intangible assets, net	616,669	670,840
Goodwill, net	1,998,608	2,089,339
Other noncurrent assets, net	43,113	90,465
Total Assets	4,496,756	4,646,459
Current Liabilities:
Accounts payable	132,966	132,611
Accrued liabilities	296,280	379,202
Income taxes payable	64,023	28,948
Notes payable and current portion of long-term debt	119,704	111,823
Total Current Liabilities	612,973	652,584
Long-term debt	1,077,779	1,150,084
Deferred income taxes	155,587	165,551
Other noncurrent liabilities	334,128	356,042
Total Liabilities	$ 2,180,467	$ 2,324,261
Commitments and contingencies
Equity:
Preferred stock, $1.00 par value; .25 million shares authorized; no shares issued	$ 0	$ 0
Common stock, $.01 par value; 200.0 million shares authorized; 162.8 million shares issued at June 30, 2015 and December 31, 2014	1,628	1,628
Capital in excess of par value	225,002	221,669
Retained earnings	3,468,364	3,380,748
Accumulated other comprehensive loss	(475,006)	(441,136)
Treasury stock, at cost, 23.0 million and 21.9 million shares at June 30, 2015 and December 31, 2014, respectively	(905,118)	(841,630)
Total DENTSPLY International Equity	2,314,870	2,321,279
Noncontrolling interests	1,419	919
Total Equity	2,316,289	2,322,198
Total Liabilities and Equity	$ 4,496,756	$ 4,646,459

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares authorized	250,000	250,000
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	162,800,000	162,800,000
Treasury stock, shares	23,000,000	21,900,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net income	$ 108,019	$ 162,934
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	38,782	42,325
Amortization	21,846	24,493
Amortization of deferred financing costs	2,177	2,285
Deferred income taxes	28,697	(4,893)
Share-based compensation expense	11,830	13,358
Restructuring and other costs - non-cash	45,814	0
Stock option income tax benefit	(8,822)	(349)
Equity in net loss from unconsolidated affiliates	12,541	657
Other non-cash income	(13,725)	(9,110)
Loss on disposal of property, plant and equipment	481	0
Changes in operating assets and liabilities, net of acquisitions:
Accounts and notes receivable-trade, net	(39,997)	(31,505)
Inventories, net	4,126	(22,427)
Prepaid expenses and other current assets, net	1,832	(6,068)
Other noncurrent assets, net	720	1,096
Accounts payable	4,938	10,613
Accrued liabilities	(17,678)	(6,228)
Income taxes	(74)	35,532
Other noncurrent liabilities	9,738	7,532
Net cash provided by operating activities	211,245	220,245
Cash flows from investing activities:
Capital expenditures	(33,434)	(48,831)
Cash paid for acquisitions of businesses, net of cash acquired	3,305	2,009
Cash received on derivatives contracts	14,267	1,674
Cash paid on derivatives contracts	810	4,006
Expenditures for identifiable intangible assets	0	(1,316)
Purchase of short-term investments	0	(1,135)
Proceeds from sale of property, plant and equipment, net	303	277
Net cash used in investing activities	(22,979)	(55,346)
Cash flows from financing activities:
Increase (decrease) in short-term borrowings	33,370	(38,087)
Cash paid for treasury stock	(98,975)	(54,586)
Cash dividends paid	(19,640)	(18,453)
Cash paid for acquisition of noncontrolling interests of consolidated subsidiary	(80,452)	(33)
Repayments on long-term borrowings	(100,232)	(75,371)
Proceeds from exercised stock options	18,597	12,736
Excess tax benefits from share-based compensation	8,822	349
Net cash used in financing activities	(238,510)	(173,445)
Effect of exchange rate changes on cash and cash equivalents	(4,923)	521
Net decrease in cash and cash equivalents	(55,167)	(8,025)
Cash and cash equivalents at beginning of period	151,639	74,954
Cash and cash equivalents at end of period	$ 96,472	$ 66,929

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Total DENTSPLY International Equity	Noncontrolling Interests
Beginning Balance at Dec. 31, 2013	$ 2,577,974	$ 1,628	$ 255,272	$ 3,095,721	$ (69,062)	$ (748,506)	$ 2,535,053	$ 42,921
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	162,934			162,871			162,871	63
Other comprehensive loss	(29,140)				(23,407)		(23,407)	(203)
Other Comprehensive Income (Loss), Net of Tax excluding Acquisition of NCI	(23,610)
Acquisition of noncontrolling interest	(87,283)		(40,283)		(5,530)		(45,813)	(41,470)
Exercise of stock options	12,736		(2,204)			14,940	12,736
Tax benefit from stock options exercised	349		349				349
Share based compensation expense	13,358		13,358				13,358
Funding of Employee Stock Ownership Plan	5,953		1,535			4,418	5,953
Treasury shares purchased	(54,586)					(54,586)	(54,586)
RSU distributions	(4,264)		(10,917)			6,653	(4,264)
RSU dividends			164	(164)
Cash dividends ($0.14500 per share)	(18,787)			(18,787)			(18,787)
Ending Balance at Jun. 30, 2014	2,584,774	1,628	217,274	3,239,641	(97,999)	(777,081)	2,583,463	1,311
Beginning Balance at Dec. 31, 2014	2,322,198	1,628	221,669	3,380,748	(441,136)	(841,630)	2,321,279	919
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	108,019			108,061			108,061	(42)
Other comprehensive loss	(33,328)				(33,870)		(33,870)	542
Exercise of stock options	18,597		(4,688)			23,285	18,597
Tax benefit from stock options exercised	8,822		8,822				8,822
Share based compensation expense	11,830		11,830				11,830
Funding of Employee Stock Ownership Plan	4,727		1,077			3,650	4,727
Treasury shares purchased	(98,998)					(98,998)	(98,998)
RSU distributions	(5,303)		(13,878)			8,575	(5,303)
RSU dividends			170	(170)
Cash dividends ($0.14500 per share)	(20,275)			(20,275)
Ending Balance at Jun. 30, 2015	$ 2,316,289	$ 1,628	$ 225,002	$ 3,468,364	$ (475,006)	$ (905,118)	$ 2,314,870	$ 1,419

CONSOLIDATED STATEMENTS OF CHA8

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Statement of Stockholders' Equity [Abstract]
Cash dividends, per share	$ 0.145	$ 0.1325

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES The accounting policies of the Company, as applied in the interim consolidated financial statements presented herein are substantially the same as presented in the Company’s Form 10-K for the year ended December 31, 2014 , except as may be indicated below: Accounts and Notes Receivable The Company records a provision for doubtful accounts, which is included in “Selling, general and administrative expenses” in the Consolidated Statements of Operations. Accounts and notes receivables – trade, net are stated net of allowances for doubtful accounts and trade discounts, which were $ 9.2 million a t June 30, 2015 and $ 8.8 million at December 31, 2014 . Marketable Securities The Company’s marketable securities consist of corporate convertible bonds that are classified as available-for-sale in “Prepaid expenses and other current assets” on the Consolidated Balance Sheets as the instruments mature in December 2015. The Company determined the appropriate classification at the time of purchase and will re-evaluate such designation as of each balance sheet date. In addition, the Company reviews the securities each quarter for indications of possible impairment. If an impairment is identified, the determination of whether the impairment is temporary or other-than-temporary requires significant judgment. The primary factors that the Company considers in making this judgment include the extent and time the fair value of each investment has been below cost and the existence of a credit loss. If a decline in fair value is judged other-than-temporary, the basis of the securities is written down to fair value and the amount of the write-down is included as a realized loss in the Consolidated Statement of Operations. Changes in fair value are reported in accumulated other comprehensive income (“AOCI”). The convertible element of the bonds has not been bifurcated from the underlying bonds as the element does not contain a net-settlement feature, nor would the Company be able to achieve a hypothetical net-settlement that would substantially place the Company in a comparable cash settlement position. As such, the derivative is not accounted for separately from the bond. The cash paid by the Company was equal to the face value of the bonds issued, and therefore, the Company has not recorded any bond premium or discount on acquiring the bonds. The fair value of the bonds was $ 153.6 million and $ 57.7 million at June 30, 2015 and December 31, 2014 , respectively. At June 30, 2015 and December 31, 2014 , a cumulative unrealized holding gain of $70.3 million and $ 8.5 million , respectively, on available-for-sale securities, net of tax, has been recorded in AOCI. As this investment is held by a euro-denominated subsidiary of the Company, the investment’s value is also impacted by changing foreign currency rates which accounts for the remaining difference between the period end values and the change in cumulative gain. New Accounting Pronouncements In April 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” This newly issued accounting standard changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. This standard will have the impact of reducing the frequency of disposals reported as discontinued operations, by requiring such a disposal to represent a strategic shift that has or will have a major effect on entity’s operations and financial results. Additionally, existing provisions that prohibit an entity from reporting a discontinued operation if it has certain continuing cash flows or involvement with the component after a disposal are eliminated by this standard. The ASU also expands the disclosures for discontinued operations and requires new disclosures related to individually significant disposals that do not qualify as discontinued operations. This Company adopted this accounting standard for the quarter ended March 31, 2015. The adoption of this standard did not materially impact the Company’s financial position or results of operations. In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” that seeks to provide a single, comprehensive revenue recognition model for all contracts with customers that improve comparability within industries, across industries and across capital markets. Under this standard, an entity should recognize revenue for the transfer of goods or services equal to the amount it expects to be entitled to receive for those goods or services. Enhanced disclosure requirements regarding the nature, timing and uncertainty of revenue and related cash flows exist. To assist entities in applying the standard, a five step model for recognizing and measuring revenue from contracts with customers has been introduced. Entities have the option to apply the new guidance retrospectively to each prior reporting period presented (full retrospective approach) or retrospectively with a cumulative effect adjustment to retained earnings for initial application of the guidance at the date of initial adoption (modified retrospective method). The Company expects to adopt this accounting standard for the quarter ended March 31, 2017. Early adoption is not permitted. On April 1, 2015, the FASB proposed deferring the effective date by one year to annual reporting periods beginning after December 15, 2017. The proposal has not been ratified. The Company is currently assessing the impact that ASU No. 2014-09 may have on their financial positions, results of operations, cash flows and disclosures, as well as, the transition method they will use to adopt the guidance In January 2015, the FASB issued ASU No. 2015-01, “Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items” This newly issued accounting standard eliminates from generally accepted accounting principles the concept of Extraordinary items, events or transactions that are unusual in nature and occur infrequently. The amendments in this update are effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2015. Prospective application and early adoption is permitted. The adoption of this standard is not expected to impact the Company’s financial position or results of operations. In April 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs.” This newly issued accounting standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct reduction from the carrying amount of that debt liability. Retrospective application is required. The amendments in this standard are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted. The Company adopted this standard during the second quarter of 2015, applying retrospective application to the periods presented in this Form 10-Q. The following is a summary of the adjustment to the financial statement line items impacted by this accounting update: December 31, 2014 (in thousands) As Reported Consolidated Balance Sheet Line Item Balance Adjustment Adjusted Balance Other noncurrent assets, net $ 94,271 (3,806 ) $ 90,465 Notes payable and current portion of long-term debt 112,831 (1,008 ) 111,823 Long-term debt 1,152,882 (2,798 ) 1,150,084 March 31, 2015 (in thousands) As Reported Consolidated Balance Sheet Line Item Balance Adjustment Adjusted Balance Other noncurrent assets, net $ 61,254 (3,568 ) $ 57,686 Notes payable and current portion of long-term debt 247,631 (948 ) 246,683 Long-term debt 1,078,823 (2,620 ) 1,076,203

STOCK COMPENSATION

STOCK COMPENSATION	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK COMPENSATION	STOCK COMPENSATION The following table represents total stock based compensation expense for non-qualified stock options, restricted stock units (“RSU”) and the tax related benefit for the three and six months ended June 30, 2015 and 2014 : Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Stock option expense $ 2,330 $ 2,829 $ 3,775 $ 4,503 RSU expense 4,272 4,366 7,408 8,085 Total stock based compensation expense $ 6,602 $ 7,195 $ 11,183 $ 12,588 Total related tax benefit $ 1,838 $ 1,979 $ 3,385 $ 3,543 For the three and six months ended June 30, 2015, stock compensation expense of $6.6 million and $11.2 million , respectively, of which, $6.4 million and $10.8 million , respectively, was recorded in Selling, general and administrative expense and $0.2 million and $0.3 million , respectively, was recorded in Cost of products sold on the Consolidated Statement of Operations. For the three and six months ended June 30, 2014, stock compensation expense of $7.2 million and $12.6 million , respectively, of which, $7.0 million and $12.2 million , respectively, was recorded in Selling, general and administrative expense and $0.2 million and $0.4 million , respectively, was recorded in Cost of products sold on the Consolidated Statement of Operations. At June 30, 2015 , the remaining unamortized compensation cost related to non-qualified stock options is $13.7 million , which will be expensed over the weighted average remaining vesting period of the options, or approximately 1.8 years. At June 30, 2015 , the unamortized compensation cost related to RSU is $26.5 million , which will be expensed over the weighted average remaining restricted period of the RSU, or approximately 1.5 years.

COMPREHENSIVE INCOME

COMPREHENSIVE INCOME	6 Months Ended
	Jun. 30, 2015
COMPREHENSIVE INCOME [Abstract]
COMPREHENSIVE INCOME	COMPREHENSIVE INCOME During the quarter ended June 30, 2015 , foreign currency translation adjustments included currency translation losses of $74.9 million and losses on the Company’s loans designated as hedges of net investments of $0.4 million . During the quarter ended June 30, 2014 , foreign currency translation adjustments included currency translation losses of $20.6 million and losses of $1.2 million on the Company’s loans designated as hedges of net investments. During the six months ended June 30, 2015, foreign currency translation adjustments included currency translation losses of $113.7 million and losses on the Company’s loans designated as hedges of net investments of $1.2 million . During the six months ended June 30, 2014, foreign currency translation adjustments included currency translation losses of $19.7 million and losses on the Company’s loans designated as hedges of net investments of $3.2 million . The cumulative foreign currency translation adjustments included translation losses of $230.7 million and $117.1 million at June 30, 2015 and December 31, 2014 , respectively, and losses on loans designated as hedges of net investments of $96.7 million and $95.4 million , respectively. These foreign currency translation adjustments were partially offset by movements on derivative financial instruments, which are discussed in Note 10 , Financial Instruments and Derivatives. Changes in AOCI, net of tax, by component for the six months ended June 30, 2015 and 2014 : (in thousands) Foreign Currency Translation Adjustments Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges Gain and (Loss) on Derivative Financial Instruments Designated as Net Investment Hedges Net Unrealized Holding Gain (Loss) on Available-for-Sale Securities Pension Liability Adjustments Total Balance at December 31, 2014 $ (212,490 ) $ (10,825 ) $ (112,728 ) $ 8,481 $ (113,574 ) $ (441,136 ) Other comprehensive income (loss) before reclassifications (114,891 ) 18,446 (2,345 ) 70,267 — (28,523 ) Amounts reclassified from accumulated other comprehensive income (loss) — (8,173 ) — — 2,826 (5,347 ) Net (decrease) increase in other comprehensive income (114,891 ) 10,273 (2,345 ) 70,267 2,826 (33,870 ) Balance at June 30, 2015 $ (327,381 ) $ (552 ) $ (115,073 ) $ 78,748 $ (110,748 ) $ (475,006 ) (in thousands) Foreign Currency Translation Adjustments Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges Gain and (Loss) on Derivative Financial Instruments Designated as Net Investment Hedges Net Unrealized Holding Gain (Loss)on Available-for-Sale Securities Pension Liability Adjustments Total Balance at December 31, 2013 $ 140,992 $ (21,753 ) $ (151,114 ) $ 12,729 $ (49,916 ) $ (69,062 ) Other comprehensive income (loss) before reclassifications (22,942 ) (2,717 ) 849 (3,803 ) 197 (28,416 ) Amounts reclassified from accumulated other comprehensive income (loss) — 4,065 — — 944 5,009 Net (decrease) increase in other comprehensive income (22,942 ) 1,348 849 (3,803 ) 1,141 (23,407 ) Foreign currency translation related to acquisition of noncontrolling interests (5,530 ) — — — — (5,530 ) Balance at June 30, 2014 $ 112,520 $ (20,405 ) $ (150,265 ) $ 8,926 $ (48,775 ) $ (97,999 ) Reclassifications out of accumulated other comprehensive income (expense) to the Consolidated Statements of Operations for the three and six months ended June 30, 2015 and 2014 : (in thousands) Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item in the Statements of Operations Three Months Ended June 30, 2015 2014 Gains and (losses) on derivative financial instruments: Interest rate swaps $ (1,074 ) $ (929 ) Interest expense Foreign exchange forward contracts 6,839 (1,651 ) Cost of products sold Foreign exchange forward contracts 181 (58 ) SG&A expenses Commodity contracts (121 ) (158 ) Cost of products sold 5,825 (2,796 ) Net gain (loss) before tax (1,189 ) 819 Tax (expense) benefit $ 4,636 $ (1,977 ) Net of tax Amortization of defined benefit pension and other postemployment benefit items: Amortization of prior service benefits $ 34 $ 35 (a) Amortization of net actuarial losses (2,015 ) (721 ) (a) (1,981 ) (686 ) Net loss before tax 572 213 Tax benefit $ (1,409 ) $ (473 ) Net of tax Total reclassifications for the period $ 3,227 $ (2,450 ) (a) These accumulated other comprehensive income components are included in the computation of net periodic benefit cost for the three months ended June 30, 2015 and 2014 (see Note 8 , Benefit Plans, for additional details). (in thousands) Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item in the Statements of Operations Six Months Ended June 30, 2015 2014 Gains and (losses) on derivative financial instruments: Interest rate swaps $ (2,040 ) $ (1,856 ) Interest expense Foreign exchange forward contracts 10,726 (3,296 ) Cost of products sold Foreign exchange forward contracts 344 (157 ) SG&A expenses Commodity contracts (250 ) (403 ) Cost of products sold 8,780 (5,712 ) Net gain (loss) before tax (607 ) 1,647 Tax (expense) benefit $ 8,173 $ (4,065 ) Net of tax Amortization of defined benefit pension and other postemployment benefit items: Amortization of prior service benefits $ 68 $ 69 (a) Amortization of net actuarial losses (4,041 ) (1,439 ) (a) (3,973 ) (1,370 ) Net loss before tax 1,147 426 Tax benefit $ (2,826 ) $ (944 ) Net of tax Total reclassifications for the period $ 5,347 $ (5,009 ) (a) These accumulated other comprehensive income components are included in the computation of net periodic benefit cost for the six months ended June 30, 2015 and 2014 (see Note 8 , Benefit Plans, for additional details).

EARNINGS PER COMMON SHARE

EARNINGS PER COMMON SHARE	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
EARNINGS PER COMMON SHARE	EARNINGS PER COMMON SHARE The following table sets forth the computation of basic and diluted earnings per common share for the three and six months ended June 30, 2015 and 2014 : Basic Earnings Per Common Share Computation Three Months Ended Six Months Ended (in thousands, except per share amounts) 2015 2014 2015 2014 Net income attributable to DENTSPLY International $ 44,099 $ 89,993 $ 108,061 $ 162,871 Weighted average common shares outstanding 139,813 141,790 140,054 141,921 Earnings per common share - basic $ 0.32 $ 0.63 $ 0.77 $ 1.15 Diluted Earnings Per Common Share Computation (in thousands, except per share amounts) Net income attributable to DENTSPLY International $ 44,099 $ 89,993 $ 108,061 $ 162,871 Weighted average common shares outstanding 139,813 141,790 140,054 141,921 Incremental weighted average shares from assumed exercise of dilutive options from stock-based compensation awards 2,449 2,374 2,467 2,367 Total weighted average diluted shares outstanding 142,262 144,164 142,521 144,288 Earnings per common share - diluted $ 0.31 $ 0.62 $ 0.76 $ 1.13 The calculation of weighted average diluted shares outstanding excludes stock options and RSU of 0.8 million and 1.0 million shares of common stock that were outstanding during the three and six months ended June 30, 2015 , respectively, because their effect would be antidilutive.

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS	6 Months Ended
	Jun. 30, 2015
Business Combinations [Abstract]
BUSINESS COMBINATIONS	BUSINESS COMBINATIONS Effective January 1, 2014, the Company recorded a liability for the contractual purchase of the remaining shares of one variable interest entity. The Company paid this obligation during the first quarter of 2015.

SEGMENT AND GEOGRAPHIC INFORMAT

SEGMENT AND GEOGRAPHIC INFORMATION	6 Months Ended
	Jun. 30, 2015
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION The Company has numerous operating businesses covering a wide range of dental and certain healthcare products and geographic regions, primarily serving the professional dental market. Professional dental products represented approximately 88% of net sales for the three and six months ended June 30, 2015 and 2014 , respectively. The operating businesses are combined into operating groups, which generally have overlapping product offerings, geographical presence, customer bases, distribution channels, and regulatory oversight. These operating groups are considered the Company’s reportable segments as the Company’s chief operating decision-maker regularly reviews financial results at the operating group level and uses this information to manage the Company’s operations. The accounting policies of the segments are consistent with those described in the Company’s most recently filed Form 10-K in the summary of significant accounting policies. The Company evaluates performance of the segments based on the groups’ net third party sales, excluding precious metal content, and segment income. The Company defines net third party sales excluding precious metal content as the Company’s net sales excluding the precious metal cost within the products sold, and this is considered a non-US GAAP measure. The Company’s exclusion of precious metal content in the measurement of net third party sales enhances comparability of performance between periods as it excludes the fluctuating market prices of the precious metal content. The Company defines segment income as net operating income after the assignment of certain direct corporate costs and before restructuring and other costs, interest expense, interest income, other expense (income), net and provision for income taxes. A description of the products and services provided within each of the Company’s three reportable segments is provided below. Significant interdependencies exist among the Company’s operations in certain geographic areas. Inter-segment sales are at prices intended to provide a reasonable profit to the manufacturing unit after recovery of all manufacturing costs and to provide a reasonable profit for purchasing locations after coverage of marketing and general and administrative costs. During the March 31, 2015 quarter, the Company realigned reporting responsibilities for multiple locations as a result of changes to the management structure. The segment information below reflects the revised structure for all periods shown. Dental Consumables, Endodontic and Dental Laboratory Businesses This segment includes responsibility for the design and manufacture of the Company’s chairside consumable products. It also has responsibilities for sales and distribution of certain small equipment and chairside consumable products in the United States, Germany and certain other European regions as well as responsibility for the sales and distribution of certain endodontic products in Germany and certain other European regions. In addition, this segment is responsible for the design, manufacture, sales and distribution of most of the Company’s dental laboratory products. This segment is also responsible for the design, manufacture, worldwide distribution and sales of certain non-dental products, excluding urological and surgery-related products Healthcare, Orthodontic and Implant Businesses This segment is responsible for the worldwide design, manufacture, sales and distribution of the Company’s healthcare products, primarily urological and surgery-related products, throughout most of the world. This segment also includes responsibility for the design, manufacture, sales and distribution of orthodontic and implant products, in most regions of the world. Additionally, segment is also responsible for the sales and distribution of most of the Company’s other dental products, including most dental consumables within Canada. Select Developed and Emerging Markets Businesses This segment has responsibilities for sales and distribution of chairside consumable, endodontic and dental laboratory products within certain European regions, Japan and Australia. This segment also includes the responsibility for the sales and distribution of most of the Company’s dental products, including most dental consumables, sold in Eastern Europe, Middle East, South America, Latin America including Mexico, Asia and Africa. The following tables set forth information about the Company’s segments for the three and six months ended June 30, 2015 and 2014 : Third Party Net Sales Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 317,376 $ 346,264 $ 627,693 $ 685,545 Healthcare, Orthodontic and Implant Businesses 252,845 279,696 488,838 544,107 Select Developed and Emerging Markets Businesses 127,785 139,265 237,795 265,687 Total net sales $ 698,006 $ 765,225 $ 1,354,326 $ 1,495,339 Third Party Net Sales, Excluding Precious Metal Content Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 301,299 $ 319,978 $ 593,390 $ 625,050 Healthcare, Orthodontic and Implant Businesses 252,665 279,478 488,476 543,681 Select Developed and Emerging Markets Businesses 120,734 131,442 224,379 251,350 Total net sales, excluding precious metal content 674,698 730,898 1,306,245 1,420,081 Precious metal content of sales 23,308 34,327 48,081 75,258 Total net sales, including precious metal content $ 698,006 $ 765,225 $ 1,354,326 $ 1,495,339 Inter-segment Net Sales Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2,014 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 89,324 $ 93,642 $ 173,213 $ 183,100 Healthcare, Orthodontic and Implant Businesses 1,578 1,970 3,352 4,431 Select Developed and Emerging Markets Businesses 3,437 2,722 6,313 6,239 All Other (a) 67,116 75,860 132,166 150,482 Eliminations (161,455 ) (174,194 ) (315,044 ) (344,252 ) Total $ — $ — $ — $ — (a) Includes amounts recorded at one distribution warehouse not managed by named segments. Segment Operating Income (Loss) Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 110,787 $ 117,976 $ 214,193 $ 224,745 Healthcare, Orthodontic and Implant Businesses 27,906 32,049 54,435 56,574 Select Developed and Emerging Markets Businesses (3,464 ) (1,211 ) (7,350 ) (2,503 ) Segment operating income 135,229 148,814 261,278 278,816 Reconciling Items (income) expense: All Other (b) 10,547 20,466 33,461 44,105 Restructuring and other costs 38,881 1,242 44,307 2,035 Interest expense 9,824 11,798 20,492 22,753 Interest income (660 ) (1,744 ) (1,402 ) (3,179 ) Other expense (income), net (376 ) 575 232 963 Income before income taxes $ 77,013 $ 116,477 $ 164,188 $ 212,139 (b) Includes the results of unassigned Corporate headquarter costs, inter-segment eliminations and one distribution warehouse not managed by named segments. Assets (in thousands) June 30, 2015 December 31, 2014 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 1,360,187 $ 1,358,018 Healthcare, Orthodontic and Implant Businesses 2,508,278 2,655,622 Select Developed and Emerging Markets Businesses 352,866 369,844 All Other (c) 275,425 262,975 Total $ 4,496,756 $ 4,646,459 (c) Includes the assets of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segments.

INVENTORIES

INVENTORIES	6 Months Ended
	Jun. 30, 2015
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories are stated at the lower of cost or market. The cost of inventories determined by the last-in, first-out (“LIFO”) method at June 30, 2015 and December 31, 2014 were $ 7.0 million and $ 6.3 million , respectively. The cost of other inventories was determined by the first-in, first-out (“FIFO”) or average cost methods. If the FIFO method had been used to determine the cost of LIFO inventories, the amounts at which net inventories are stated would be higher than reported at June 30, 2015 and December 31, 2014 by $ 6.2 million and $ 6.1 million , respectively. Inventories, net of inventory valuation reserves, consist of the following: (in thousands) June 30, 2015 December 31, 2014 Finished goods $ 242,921 $ 253,333 Work-in-process 59,858 58,329 Raw materials and supplies 72,041 75,433 Inventories, net $ 374,820 $ 387,095 The inventory valuation reserves were $ 36.3 million and $ 34.1 million at June 30, 2015 and December 31, 2014 , respectively.

BENEFIT PLANS

BENEFIT PLANS	6 Months Ended
	Jun. 30, 2015
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
BENEFIT PLANS	BENEFIT PLANS The following sets forth the components of net periodic benefit cost of the Company’s defined benefit plans and for the Company’s other postemployment benefit plans for the three and six months ended June 30, 2015 and 2014 : Defined Benefit Plans Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Service cost $ 4,343 $ 3,549 $ 8,691 $ 7,101 Interest cost 1,843 2,861 3,697 5,726 Expected return on plan assets (1,399 ) (1,391 ) (2,777 ) (2,777 ) Amortization of prior service credit (35 ) (35 ) (69 ) (69 ) Amortization of net actuarial loss 1,963 709 3,947 1,417 Net periodic benefit cost $ 6,715 $ 5,693 $ 13,489 $ 11,398 Other Postemployment Benefit Plans Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Service cost $ 88 $ 44 $ 177 $ 89 Interest cost 144 140 288 280 Amortization of net actuarial loss 43 12 85 22 Net periodic benefit cost $ 275 $ 196 $ 550 $ 391 The following sets forth the information related to the contributions to the Company’s benefit plans for 2015 : (in thousands) Pension Benefits Other Postemployment Benefits Actual contributions through June 30, 2015 $ 5,559 $ 192 Projected contributions for the remainder of the year 5,945 449 Total projected contributions $ 11,504 $ 641

RESTRUCTURING AND OTHER COSTS

RESTRUCTURING AND OTHER COSTS	6 Months Ended
	Jun. 30, 2015
Restructuring and Related Activities [Abstract]
RESTRUCTURING AND OTHER COSTS	RESTRUCTURING AND OTHER COSTS Restructuring Costs During the three and six months ended June 30, 2015 , the Company recorded net restructuring costs and other costs of $38.9 million and $44.3 million , respectively. On May 22, 2015, the Company announced that it reorganized portions of its laboratory business and associated manufacturing capabilities within the Dental Consumables, Endodontics and Dental Laboratory Businesses segment. During the June 2015 quarter, the Company recorded $31.0 million of costs that consist primarily of employee severance benefits related to these and other similar actions. Also during the three and six months ended June 30, 2015 , the Company recorded restructuring costs of $2.7 million and $7.5 million , respectively, within the Healthcare, Orthodontic and Implant Businesses segment primarily related to the global efficiency initiative During the three and six months ended June 30, 2014 , the Company recorded net restructuring and other costs of $1.2 million and $2.0 million . These costs are recorded in “Restructuring and other costs” in the Consolidated Statements of Operations and the associated liabilities are recorded in “Accrued liabilities” in the Consolidated Balance Sheets. At June 30, 2015 , the Company’s restructuring accruals were as follows: Severance (in thousands) 2013 and Prior Plans 2014 Plans 2015 Plans Total Balance at December 31, 2014 $ 951 $ 5,062 $ — $ 6,013 Provisions 81 431 40,958 41,470 Amounts applied (635 ) (3,084 ) (3,542 ) (7,261 ) Change in estimates (76 ) (74 ) (547 ) (697 ) Balance at June 30, 2015 $ 321 $ 2,335 $ 36,869 $ 39,525 Lease/Contract Terminations (in thousands) 2013 and Prior Plans 2014 Plans 2015 Plans Total Balance at December 31, 2014 $ 535 $ 1,636 $ — $ 2,171 Provisions — 12 270 282 Amounts applied (105 ) (384 ) — (489 ) Change in estimates — (10 ) — (10 ) Balance at June 30, 2015 $ 430 $ 1,254 $ 270 $ 1,954 Other Restructuring Costs (in thousands) 2013 and Prior Plans 2014 Plans 2015 Plans Total Balance at December 31, 2014 $ 25 $ 1,049 $ — $ 1,074 Provisions 2 168 577 747 Amounts applied (2 ) (799 ) (227 ) (1,028 ) Change in estimate — 28 — 28 Balance at June 30, 2015 $ 25 $ 446 $ 350 $ 821 The following table provides the year-to-date changes in the restructuring accruals by segment: (in thousands) December 31, 2014 Provisions Amounts Applied Change in Estimates June 30, 2015 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 5,272 $ 31,522 $ (3,941 ) $ — $ 32,853 Healthcare, Orthodontic and Implant Businesses 3,828 7,517 (4,558 ) (679 ) 6,108 Select Developed and Emerging Markets Businesses 91 1,719 (177 ) — 1,633 All Other 67 1,741 (102 ) — 1,706 Total $ 9,258 $ 42,499 $ (8,778 ) $ (679 ) $ 42,300

FINANCIAL INSTRUMENTS AND DERIV

FINANCIAL INSTRUMENTS AND DERIVATIVES	6 Months Ended
	Jun. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instrument and Derivatives	FINANCIAL INSTRUMENTS AND DERIVATIVES Derivative Instruments and Hedging Activities The Company’s activities expose it to a variety of market risks, which primarily include the risks related to the effects of changes in foreign currency exchange rates, interest rates and commodity prices. These financial exposures are monitored and managed by the Company as part of its overall risk management program. The objective of this risk management program is to reduce the volatility that these market risks may have on the Company’s operating results and equity. The Company employs derivative financial instruments to hedge certain anticipated transactions, firm commitments, or assets and liabilities denominated in foreign currencies. Additionally, the Company utilizes interest rate swaps to convert variable rate debt to fixed rate debt and to convert fixed rate debt to variable rate debt, cross currency basis swaps to convert debt denominated in one currency to another currency and commodity swaps to fix certain variable raw material costs. Derivative Instruments Designated as Hedging Cash Flow Hedges The following table summarizes the notional amounts of cash flow hedges by derivative instrument type at June 30, 2015 and the notional amounts expected to mature during the next 12 months, with a discussion of the various cash flow hedges by derivative instrument type following the table: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in thousands) Foreign exchange forward contracts $ 337,017 $ 253,842 Interest rate swaps 172,169 — Commodity contracts 1,396 1,396 Total derivative instruments designated as cash flow hedges $ 510,582 $ 255,238 Foreign Exchange Risk Management The Company uses a layered hedging program to hedge select anticipated foreign currency cash flows to reduce volatility in both cash flows and reported earnings of the consolidated Company. The Company accounts for the designated foreign exchange forward contracts as cash flow hedges. As a result, the Company records the fair value of the contracts primarily through AOCI based on the tested effectiveness of the foreign exchange forward contracts. The Company measures the effectiveness of cash flow hedges of anticipated transactions on a spot-to-spot basis rather than on a forward-to-forward basis. Accordingly, the spot-to-spot change in the derivative fair value will be deferred in AOCI and released and recorded on the Consolidated Statements of Operations in the same period that the hedged transaction is recorded. The time value component of the fair value of the derivative is deemed ineffective and is reported currently in “Other expense (income), net” on the Consolidated Statements of Operations in the period which it is applicable. Any cash flows associated with these instruments are included in cash from operating activities on the Consolidated Statements of Cash Flows. The Company hedges various currencies, with the most significant activity occurring in euros, Swedish kronor, Canadian dollars, and Swiss francs. These foreign exchange forward contracts generally have maturities up to 18 months and the counterparties to the transactions are typically large international financial institutions. Interest Rate Risk Management The Company uses interest rate swaps to convert a portion of its variable interest rate debt to fixed interest rate debt. At June 30, 2015 , the Company has two significant exposures hedged with interest rate contracts. One exposure is hedged with derivative contracts having notional amounts totaling 12.6 billion Japanese yen, which effectively converts the underlying variable interest rate debt facility to a fixed interest rate of 0.9% for an intial term of five years ending September 2019. Another exposure hedged with derivative contracts has a notional amount of 65.0 million Swiss francs, and effectively converts the underlying variable interest rate of a Swiss franc denominated loan to a fixed interest rate of 0.7% for an initial term of five years, ending in September 2016. The Company enters into interest rate swap contracts infrequently as they are only used to manage interest rate risk on long-term debt instruments and not for speculative purposes. Any cash flows associated with these instruments are included in cash from operating activities on the Consolidated Statements of Cash Flows. Commodity Risk Management The Company enters into precious metal commodity swap contracts to effectively fix certain variable raw material costs typically for up to 18 months. These swaps are used to stabilize the cost of components used in the production of certain of the Company’s products. The Company generally accounts for the commodity swaps as cash flow hedges. As a result, the Company records the fair value of the contracts primarily through AOCI based on the tested effectiveness of the commodity swaps. The Company measures the effectiveness of cash flow hedges of anticipated transactions on a spot-to-spot basis rather than on a forward-to-forward basis. Accordingly, the spot-to-spot change in the derivative fair value will be deferred in AOCI and released and recorded on the Consolidated Statements of Operations in the same period that the hedged transaction is recorded. The time value component of the fair value of the derivative is deemed ineffective and is reported currently in “Interest expense” on the Consolidated Statements of Operations in the period which it is applicable. Any cash flows associated with these instruments are included in cash from operating activities on the Consolidated Statements of Cash Flows. The following tables summarize the amount of gains (losses) recorded in AOCI in the Consolidated Balance Sheets and income (expense) in the Company’s Consolidated Statements of Operations related to all cash flow hedges for the three months ended June 30, 2015 and 2014 : June 30, 2015 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in thousands) Effective Portion: Interest rate swaps $ (58 ) Interest expense $ (1,074 ) $ — Foreign exchange forward contracts (2,069 ) Cost of products sold 6,839 — Foreign exchange forward contracts (139 ) SG&A expenses 181 — Commodity contracts (96 ) Cost of products sold (121 ) — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (160 ) Commodity contracts — Interest expense — (4 ) Total in cash flow hedging $ (2,362 ) $ 5,825 $ (164 ) June 30, 2014 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in thousands) Effective Portion: Interest rate swaps $ (149 ) Interest expense $ (929 ) $ — Foreign exchange forward contracts (4,636 ) Cost of products sold (1,651 ) — Foreign exchange forward contracts 45 SG&A expenses (58 ) — Commodity contracts 101 Cost of products sold (158 ) — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (151 ) Commodity contracts — Interest expense — (11 ) Total for cash flow hedging $ (4,639 ) $ (2,796 ) $ (162 ) The following tables summarize the amount of gains (losses) recorded in AOCI in the Consolidated Balance Sheets and income (expense) in the Company’s Consolidated Statements of Operations related to all cash flow hedges for the six months ended June 30, 2015 and 2014 : June 30, 2015 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in thousands) Effective Portion: Interest rate swaps $ (1,239 ) Interest expense $ (2,040 ) $ — Foreign exchange forward contracts 22,018 Cost of products sold 10,726 — Foreign exchange forward contracts 324 SG&A expenses 344 — Commodity contracts (96 ) Cost of products sold (250 ) — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — 167 Commodity contracts — Interest expense — (8 ) Total in cash flow hedging $ 21,007 $ 8,780 $ 159 June 30, 2014 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in thousands) Effective Portion: Interest rate swaps $ (537 ) Interest expense $ (1,856 ) $ — Foreign exchange forward contracts (3,569 ) Cost of products sold (3,296 ) — Foreign exchange forward contracts 35 SG&A expenses (157 ) — Commodity contracts 203 Cost of products sold (403 ) — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (45 ) Commodity contracts — Interest expense — (24 ) Total for cash flow hedging $ (3,868 ) $ (5,712 ) $ (69 ) Overall, the derivatives designated as cash flow hedges are considered to be highly effective. At June 30, 2015 , the Company expects to reclassify $9.6 million of deferred net gains on cash flow hedges recorded in AOCI to the Consolidated Statements of Operations during the next 12 months. This reclassification is primarily due to the sale of inventory that includes hedged purchases and recognized interest expense on interest rate swaps. The term over which the Company is hedging exposures to variability of cash flows (for all forecasted transactions, excluding interest payments on variable interest rate debt) is typically 18 months. For the rollforward of derivative instruments designated as cash flow hedges in AOCI see Note 3 , Comprehensive Income. Hedges of Net Investments in Foreign Operations The Company has significant investments in foreign subsidiaries the most significant of which are denominated in euros, Swiss francs, Japanese yen and Swedish kronor. The net assets of these subsidiaries are exposed to volatility in currency exchange rates. The Company employs both derivative and non-derivative financial instruments to hedge a portion of this exposure . The derivative instruments consist of foreign exchange forward contracts and cross currency basis swaps. The non-derivative instruments consist of foreign currency denominated debt held at the parent company level. Translation gains and losses related to the net assets of the foreign subsidiaries are offset by gains and losses in derivative and non-derivative financial instruments designated as hedges of net investments, which are included in AOCI. Any cash flows associated with these instruments are included in investing activities on the Consolidated Statements of Cash Flows except for derivative instruments that include an other-than-insignificant financing element, in which case all cash flows will be classified as financing activities on the Consolidated Statements of Cash Flows. The following table summarizes the notional amounts of hedges of net investments by derivative instrument type at June 30, 2015 and the notional amounts expected to mature during the next 12 months: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in thousands) Foreign exchange forward contracts $ 420,892 $ 236,079 The fair value of the cross currency basis swaps and foreign exchange forward contracts is the estimated amount the Company would receive or pay at the reporting date, taking into account the effective interest rates, cross currency swap basis rates and foreign exchange rates. The effective portion of the change in the value of these derivatives is recorded in AOCI, net of tax effects. The following tables summarize the amount of gains (losses) recorded in AOCI on the Consolidated Balance Sheets and other income (expense) on the Company’s Consolidated Statements of Operations related to the hedges of net investments for the three months ended June 30, 2015 and 2014 : June 30, 2015 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in thousands) Effective Portion: Foreign exchange forward contracts $ (15,819 ) Other expense (income), net $ 1,191 Total for net investment hedging $ (15,819 ) $ 1,191 June 30, 2014 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in thousands) Effective Portion: Cross currency basis swaps $ 1,572 Interest income $ 674 Interest expense (384 ) Foreign exchange forward contracts 1,272 Other expense (income), net (73 ) Total for net investment hedging $ 2,844 $ 217 The following table summarizes the amount of gains (losses) recorded in AOCI on the Consolidated Balance Sheets and other income (expense) on the Company’s Consolidated Statement of Operations related to the hedges of net investments for the six months ended June 30, 2015 and 2014 : June 30, 2015 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in thousands) Effective Portion: Foreign exchange forward contracts $ (3,320 ) Other expense (income), net $ 855 Total for net investment hedging $ (3,320 ) $ 855 June 30, 2014 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in thousands) Effective Portion: Cross currency basis swaps $ (3,087 ) Interest income $ 1,351 Interest expense 157 Foreign exchange forward contracts 4,341 Other expense (income), net 175 Total for net investment hedging $ 1,254 $ 1,683 Fair Value Hedges The Company uses interest rate swaps to convert a portion of its fixed interest rate debt to variable interest rate debt. The Company has U.S. dollar denominated interest rate swaps with an initial total notional value of $150.0 million to effectively convert the underlying fixed interest rate of 4.1% on the Company’s $250.0 million Private Placement Notes (“PPN”) to variable rate for an initial term of five years, ending February 2016. The notional value of the swaps will decline proportionately as portions of the PPN mature. These interest rate swaps are designated as fair value hedges of the interest rate risk associated with the hedged portion of the fixed rate PPN. Accordingly, the Company will carry the portion of the hedged debt at fair value, with the change in debt and swaps offsetting each other on the Consolidated Statements of Operations. Any cash flows associated with these instruments are included in operating activities on the Consolidated Statements of Cash Flows. The following table summarizes the notional amounts of fair value hedges by derivative instrument type at June 30, 2015 and the notional amounts expected to mature during the next 12 months: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in thousands) Interest rate swaps $ 45,000 $ 45,000 The following tables summarize the amount of income (expense) recorded on the Company’s Consolidated Statements of Operations related to the hedges of fair value for the three and six months ended June 30, 2015 and 2014 : Consolidated Statements of Operations Location Three Months Ended June 30, Six Months Ended June 30, (in thousands) 2015 2014 2015 2014 Interest rate swaps Interest expense $ 41 $ 133 $ 158 $ 220 Derivative Instruments Not Designated as Hedges The Company enters into derivative instruments with the intent to partially mitigate the foreign exchange revaluation risk associated with recorded assets and liabilities that are denominated in a non-functional currency. The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances and are recorded in “Other expense (income), net” on the Consolidated Statements of Operations. The Company primarily uses foreign exchange forward contracts and cross currency basis swaps to hedge these risks. Any cash flows associated with the foreign exchange forward contracts and interest rate swaps not designated as hedges are included in cash from operating activities on the Consolidated Statements of Cash Flows. Any cash flows associated with the cross currency basis swaps not designated as hedges are included in investing activities on the Consolidated Statements of Cash Flows except for derivative instruments that include an other-than-insignificant financing element, in which case the cash flows will be classified as financing activities on the Consolidated Statements of Cash Flows. The following tables summarize the aggregate notional amounts of the Company’s economic hedges not designated as hedges by derivative instrument types at June 30, 2015 and the notional amounts expected to mature during the next 12 months: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in thousands) Foreign exchange forward contracts $ 478,338 $ 478,338 Interest rate swaps 2,213 805 Total for instruments not designated as hedges $ 480,551 $ 479,143 The Company had a Swiss franc denominated cross currency basis swaps to offset an intercompany Swiss franc note receivable at a U.S. dollar functional entity. The hedge matured during the second quarter of 2015 to coincide with the repayment of the note. The following table summarizes the amounts of gains (losses) recorded on the Company’s Consolidated Statements of Operations related to the economic hedges not designated as hedging for the three and six months ended June 30, 2015 and 2014 : Consolidated Statements of Operations Location Gain (Loss) Recognized Three Months Ended June 30, (in thousands) 2015 2014 Foreign exchange forward contracts (a) Other expense (income), net $ (766 ) $ (716 ) DIO equity option contracts Other expense (income), net 102 90 Interest rate swaps Interest expense 1 (16 ) Cross currency basis swaps (a) Other expense (income), net (603 ) (4,005 ) Total for instruments not designated as hedges $ (1,266 ) $ (4,647 ) (a) The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances which are recorded in “Other expense (income), net” on the Consolidated Statements of Operations. Consolidated Statements of Operations Location Gain (Loss) Recognized Six Months Ended June 30, (in thousands) 2015 2014 Foreign exchange forward contracts (a) Other expense (income), net $ 7,789 $ (5,157 ) DIO equity option contracts Other expense (income), net 107 (138 ) Interest rate swaps Interest expense (2 ) (27 ) Cross currency basis swaps (a) Other expense (income), net (1,825 ) (3,180 ) Total for instruments not designated as hedges $ 6,069 $ (8,502 ) (a) The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances which are recorded in “Other expense (income), net” on the Consolidated Statements of Operations. Consolidated Balance Sheets Location of Derivative Fair Values The following tables summarize the fair value and consolidated balance sheet location of the Company’s derivatives at June 30, 2015 and December 31, 2014 : June 30, 2015 (in thousands) Prepaid Expenses and Other Current Assets, Net Other Noncurrent Assets, Net Accrued Liabilities Other Noncurrent Liabilities Designated as Hedges Foreign exchange forward contracts $ 32,398 $ 1,833 $ 1,490 $ 2,675 Commodity contracts — — 152 — Interest rate swaps 324 282 1,164 742 Total $ 32,722 $ 2,115 $ 2,806 $ 3,417 Not Designated as Hedges Foreign exchange forward contracts $ 7,273 $ — $ 3,465 $ — Interest rate swaps — — 51 77 Total $ 7,273 $ — $ 3,516 $ 77 December 31, 2014 (in thousands) Prepaid Other Noncurrent Assets, Net Accrued Liabilities Other Noncurrent Liabilities Designated as Hedges Foreign exchange forward contracts $ 28,036 $ 12,542 $ 2,740 $ 1,707 Commodity contracts — — 233 — Interest rate swaps 617 135 575 377 Total $ 28,653 $ 12,677 $ 3,548 $ 2,084 Not Designated as Hedges Foreign exchange forward contracts $ 4,798 $ — $ 4,764 $ — DIO equity option contracts — — — 115 Interest rate swaps — — 63 129 Cross currency basis swaps 2,683 — — — Total $ 7,481 $ — $ 4,827 $ 244 Balance Sheet Offsetting Substantially all of the Company’s derivative contracts are subject to netting arrangements, whereby the right to offset occurs in the event of default or termination in accordance with the terms of the arrangements with the counterparty. While these contracts contain the enforceable right to offset through netting arrangements with the same counterparty, the Company elects to present them on a gross basis on the Consolidated Balance Sheets. Offsetting of financial assets and liabilities under netting arrangements at June 30, 2015 : Gross Amounts Not Offset in the Consolidated Balance Sheets (in thousands) Gross Amounts Recognized Gross Amount Offset in the Consolidated Balance Sheets Net Amounts Presented in the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Assets Foreign exchange forward contracts $ 41,504 $ — $ 41,504 $ (9,363 ) $ — $ 32,141 Interest rate swaps 606 — 606 (173 ) — 433 Total Assets $ 42,110 $ — $ 42,110 $ (9,536 ) $ — $ 32,574 Gross Amounts Not Offset in the Consolidated Balance Sheets (in thousands) Gross Amounts Recognized Gross Amount Offset in the Consolidated Balance Sheets Net Amounts Presented in the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Liabilities Foreign exchange forward contracts $ 7,630 $ — $ 7,630 $ (7,630 ) $ — $ — Commodity contracts 152 — 152 — — 152 Interest rate swaps 2,034 — 2,034 (1,906 ) — 128 Total Liabilities $ 9,816 $ — $ 9,816 $ (9,536 ) $ — $ 280 Offsetting of financial assets and liabilities under netting arrangements at December 31, 2014 : Gross Amounts Not Offset in the Consolidated Balance Sheets (in thousands) Gross Amounts Recognized Gross Amount Offset in the Consolidated Balance Sheets Net Amounts Presented in the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Assets Foreign exchange forward contracts $ 45,377 $ — $ 45,377 $ (7,797 ) $ — $ 37,580 Interest rate swaps 751 — 751 (274 ) — 477 Cross currency basis swaps 2,683 — 2,683 (1,067 ) — 1,616 Total Assets $ 48,811 $ — $ 48,811 $ (9,138 ) $ — $ 39,673 Gross Amounts Not Offset in the Consolidated Balance Sheets (in thousands) Gross Amounts Recognized Gross Amount Offset in the Consolidated Balance Sheets Net Amounts Presented in the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Liabilities Foreign exchange forward contracts $ 9,208 $ — $ 9,208 $ (8,186 ) $ — $ 1,022 Commodity contracts 235 — 235 — — 235 DIO equity option contracts 115 — 115 — — 115 Interest rate swaps 1,145 — 1,145 (952 ) — 193 Total Liabilities $ 10,703 $ — $ 10,703 $ (9,138 ) $ — $ 1,565

FAIR VALUE MEASUREMENT

FAIR VALUE MEASUREMENT	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENT	FAIR VALUE MEASUREMENT The Company records financial instruments at fair value with unrealized gains and losses related to certain financial instruments reflected in AOCI on the Consolidated Balance Sheets. In addition, the Company recognizes certain liabilities at fair value. The Company applies the market approach for recurring fair value measurements. Accordingly, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value of financial instruments is determined by reference to various market data and other valuation techniques as appropriate. The Company believes the carrying amounts of cash and cash equivalents, accounts receivable (net of allowance for doubtful accounts), prepaid expenses and other current assets, accounts payable, accrued liabilities, income taxes payable and notes payable approximate fair value due to the short-term nature of these instruments. The Company estimated the fair value and carrying value of total long-term debt, including the current portion, was $ 1,195.3 million and $ 1,161.5 million , respectively at June 30, 2015 . At December 31, 2014 , the Company estimated the fair value and carrying value, including the current portion, was $ 1,286.2 million and $ 1,258.9 million , respectively. The interest rate on the $ 450.0 million Senior Notes, the $ 300.0 million Senior Notes, and the $ 250.0 million PPN are fixed rates of 4.1% , 2.8% and 4.1% , respectively, and their fair value is based on the interest rates as of June 30, 2015 . The interest rates on variable rate term loan debt and commercial paper are consistent with current market conditions, therefore the fair value of these instruments approximates their carrying values. The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis at June 30, 2015 and December 31, 2014 , which are classified as “Cash and cash equivalents,” “Prepaid expenses and other current assets, net,” “Other noncurrent assets, net,” “Accrued liabilities,” and “Other noncurrent liabilities” in the Consolidated Balance Sheets. Financial assets and liabilities that are recorded at fair value as of the balance sheet date are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. June 30, 2015 (in thousands) Total Level 1 Level 2 Level 3 Assets Interest rate swaps $ 606 $ — $ 606 $ — Foreign exchange forward contracts 41,504 — 41,504 — DIO Corporation convertible bonds 153,613 — — 153,613 Total assets $ 195,723 $ — $ 42,110 $ 153,613 Liabilities Interest rate swaps $ 2,034 $ — $ 2,034 $ — Commodity contracts 152 — 152 — Foreign exchange forward contracts 7,630 — 7,630 — Long-term debt 45,326 — 45,326 — Total liabilities $ 55,142 $ — $ 55,142 $ — December 31, 2014 (in thousands) Total Level 1 Level 2 Level 3 Assets Interest rate swaps $ 752 $ — $ 752 $ — Cross currency basis swaps 2,683 — 2,683 — Foreign exchange forward contracts 45,376 — 45,376 — DIO Corporation convertible bonds 57,698 — — 57,698 Total assets $ 106,509 $ — $ 48,811 $ 57,698 Liabilities Interest rate swaps $ 1,144 $ — $ 1,144 $ — Commodity contracts 233 — 233 — Foreign exchange forward contracts 9,211 — 9,211 — Long-term debt 106,023 — 106,023 — DIO equity option contracts 115 — — 115 Total liabilities $ 116,726 $ — $ 116,611 $ 115 Derivative valuations are based on observable inputs to the valuation model including interest rates, foreign currency exchange rates, future commodities prices and credit risks. As discussed in Note 10 , Financial Instruments and Derivatives, commodity contracts, certain interest rate swaps and foreign exchange forward contracts are considered cash flow hedges. In addition, certain cross currency basis swaps and foreign exchange forward contracts are considered hedges of net investments in foreign operations. The Company uses the income method valuation technique to estimate the fair value of the DIO Corporation convertible bonds. The significant unobservable inputs for valuing the corporate bonds are both the DIO Corporation’s stock volatility factor of approximately 40% and corporate bond rating which implies approximately a 8.73% discount rate on the valuation model. Significant observable inputs used to value the corporate bonds include foreign exchange rates and DIO Corporation’s period-ending market stock price. The Company has valued the DIO equity option contracts using a Monte Carlo simulation which uses several estimates and probability assumptions by management including the future stock price, the stock price as a multiple of DIO earnings and the probability of the sellers to reduce their shares held by selling into the open market. The fair value of equity option contracts are reported in “Prepaid expenses and other current assets” on the Consolidated Balance Sheets and changes in the fair value are reported in “Other expense (income), net” in the Consolidated Statements of Operations. The following table presents a rollforward of the Company’s Level 3 holdings measured at fair value on a recurring basis using unobservable inputs: (in thousands) DIO Corporation Convertible Bonds DIO Equity Options Contracts Balance at December 31, 2014 $ 57,698 $ (115 ) Unrealized gain: Reported in AOCI, pretax 101,351 — Unrealized gain: Reported in other expense (income), net — 107 Effects of exchange rate changes (5,436 ) 8 Balance at June 30, 2015 $ 153,613 $ — For the six months ended June 30, 2015 , there were no purchases, issuances or transfers of Level 3 financial instruments.

INCOME TAXES

INCOME TAXES	6 Months Ended
	Jun. 30, 2015
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Uncertainties in Income Taxes The Company recognizes in the interim consolidated financial statements, the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position. It is reasonably possible that certain amounts of unrecognized tax benefits will significantly increase or decrease within 12 months of the reporting date of the Company’s interim consolidated financial statements. Final settlement and resolution of outstanding tax matters in various jurisdictions during the next twelve months could include unrecognized tax benefits of approximately $ 2.2 million . Of this total, approximately $ 0.9 million represents the amount of unrecognized tax benefits that, if recognized would affect the effective income tax rate. In addition, expiration of statutes of limitation in various jurisdictions during the next 12 months could include unrecognized tax benefits of approximately $0.4 million . Other Tax Matters For the three months ended June 30, 2015 , the Company recorded $3.1 million of tax expense related to prior year tax matters. In addition, the Company’s effective tax rate was unfavorably impacted by the Company’s change in the mix of consolidated earnings.

FINANCING ARRANGEMENTS

FINANCING ARRANGEMENTS	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
FINANCING ARRANGEMENTS	FINANCING ARRANGEMENTS During the quarter ended March 31, 2015, the Company paid the second required payment of $100.0 million under the Private Placement Notes “PPN” by issuing commercial paper. The final required payment of $75.0 million due in February 2016 has been classified as current on the Consolidated Balance Sheets. The second annual installment under the terms of the PNC Term Loan in the amount of $8.8 million will be due in August 2015 and has been classified as current on the Consolidated Balance Sheets. At June 30, 2015 , there was $30.0 million in outstanding borrowings, in the form of issued commercial paper, under the current $500.0 million multi-currency revolving credit facility and is classified as current on the Consolidated Balance Sheets. Effective July 1, 2015, the Company amended the multi-currency revolving credit facility to extend the maturity date by one year until July 23, 2020. The Company is able to borrow up to $500.0 million through July 23, 2019 and up to $452.0 million through July 23, 2020. The Company’s revolving credit facility, term loans and PPN contain certain affirmative and negative covenants relating to the Company's operations and financial condition. At June 30, 2015 , the Company was in compliance with all debt covenants. At June 30, 2015 , the Company had $526 million of borrowing available under lines of credit, including lines available under its short-term arrangements and revolving credit agreement.

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	6 Months Ended
	Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS The Company performed the required annual impairment tests of goodwill as of April 30, 2015 on 16 reporting units. As discussed in Note 6, Segment Information, effective in the first quarter of 2015, the Company realigned reporting responsibilities for multiple locations. For any realignment that resulted in reporting unit changes, the Company applied the relative fair value method to determine the reallocation of goodwill of the associated reporting units. To determine the fair value of the Company’s reporting units, the Company uses a discounted cash flow model with market-based support as its valuation technique to measure the fair value for its reporting units. The discounted cash flow model uses five-year forecasted cash flows plus a terminal value based on a multiple of earnings. In addition, the Company applies gross margin and operating expense assumptions consistent with historical trends. The total cash flows were discounted based on a range between 7.6% to 12.5% , which included assumptions regarding the Company’s weighted-average cost of capital. The Company considered the current market conditions both in the U.S. and globally, when determining its assumptions. Lastly, the Company reconciled the aggregated fair values of its reporting units to its market capitalization, which included a reasonable control premium based on market conditions. As a result of the annual impairment tests of goodwill, no impairment was identified. In addition, the Company assessed the annual impairment of indefinite-lived intangible assets as of April 30, 2015, which largely consists of acquired tradenames, in conjunction with the annual impairment tests of goodwill. The performance of the Company’s annual impairment test did not result in any impairment of the Company’s indefinite-lived assets. A reconciliation of changes in the Company’s goodwill is as follows: (in thousands) Dental Consumables, Endodontic and Dental Laboratory Businesses Healthcare, Orthodontic and Implant Businesses Select Developed and Emerging Markets Businesses Total Balance at December 31, 2014 $ 565,714 $ 1,394,398 $ 129,227 $ 2,089,339 Effects of exchange rate changes (6,268 ) (76,509 ) (7,954 ) (90,731 ) Balance at June 30, 2015 $ 559,446 $ 1,317,889 $ 121,273 $ 1,998,608 Identifiable definite-lived and indefinite-lived intangible assets consist of the following: June 30, 2015 December 31, 2014 (in thousands) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Patents $ 165,615 $ (91,135 ) $ 74,480 $ 175,186 $ (95,526 ) $ 79,660 Trademarks 68,271 (38,027 ) 30,244 75,645 (37,053 ) 38,592 Licensing agreements 34,071 (23,629 ) 10,442 34,638 (22,806 ) 11,832 Customer relationships 433,627 (114,086 ) 319,541 452,882 (104,703 ) 348,179 Total definite-lived $ 701,584 $ (266,877 ) $ 434,707 $ 738,351 $ (260,088 ) $ 478,263 Indefinite-lived Trademarks and In-process R&D $ 181,962 $ — $ 181,962 $ 192,577 $ — $ 192,577 Total identifiable intangible assets $ 883,546 $ (266,877 ) $ 616,669 $ 930,928 $ (260,088 ) $ 670,840 During the three and six months ended June 30, 2015 , the Company impaired a trademark for $3.7 million that was held in the Dental Consumable, Endodontics and Dental Laboratory Businesses segment which was recorded in “Restructuring and other costs” in the Consolidated Statements of Operations.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Litigation On June 18, 2004, Marvin Weinstat, DDS and Richard Nathan, DDS filed a class action suit in San Francisco County, California alleging that the Company misrepresented that its Cavitron® ultrasonic scalers are suitable for use in oral surgical procedures. The Complaint seeks a recall of the product and refund of its purchase price to dentists who have purchased it for use in oral surgery. The Court certified the case as a class action in June 2006 with respect to the breach of warranty and unfair business practices claims. The class that was certified is defined as California dental professionals who, at any time during the period beginning June 18, 2000 through September 14, 2012, purchased and used one or more Cavitron® ultrasonic scalers for the performance of oral surgical procedures on their patients, which Cavitrons® were accompanied by Directions for Use that “Indicated” Cavitron® use for “periodontal debridement for all types of periodontal disease.” The case went to trial in September 2013, and on January 22, 2014, the San Francisco Superior Court issued its decision in the Company’s favor, rejecting all of the plaintiffs’ claims. The plaintiffs have appealed the Superior Court’s decision, and the appeal is now pending. The Company is defending against this appeal. On December 12, 2006, a Complaint was filed by Carole Hildebrand, DDS and Robert Jaffin, DDS in the Eastern District of Pennsylvania (the Plaintiffs subsequently added Dr. Mitchell Goldman as a named class representative). The case was filed by the same law firm that filed the Weinstat case in California. The Complaint asserts putative class action claims on behalf of dentists located in New Jersey and Pennsylvania. The Complaint seeks damages and asserts that the Company’s Cavitron® ultrasonic scaler was negligently designed and sold in breach of contract and warranty arising from misrepresentations about the potential uses of the product because it cannot assure the delivery of potable or sterile water. Following grant of a Company Motion and dismissal of the case for lack of jurisdiction, the plaintiffs filed a second complaint under the name of Dr. Hildebrand’s corporate practice, Center City Periodontists, asserting the same allegations (this case is now proceeding under the name “Center City Periodontists”). The plaintiffs moved to have the case certified as a class action, to which the Company has objected and filed its brief. The Court subsequently granted a Motion filed by the Company and dismissed plaintiffs’ New Jersey Consumer Fraud and negligent design claims, leaving only a breach of express warranty claim, in response to which the Company has filed a Motion for Summary Judgment. The Court has rescheduled a hearing to January 2016 on plaintiffs’ class certification motion. On January 20, 2014, the Company was served with a qui tam complaint filed by two former and one current employee of the Company under the Federal False Claims Act and equivalent state and city laws. The lawsuit was previously under seal in the U.S. District Court for the Eastern District of Pennsylvania . The complaint alleges, among other things, that the Company engaged in various illegal marketing activities, and thereby caused dental and other healthcare professionals to file false claims for reimbursement with Federal and State governments. The relators seek injunctive relief, fines, treble damages, and attorneys’ fees and costs. On January 27, 2014, the United States filed with the Court a notice that it had elected not to intervene in the qui tam action at this time. The United States’ notice indicated that the named state and city co-plaintiffs had authorized the United States to communicate to the Court that they also had decided not to intervene at this time. These non-intervention decisions do not prevent the qui tam relators from litigating this action, and the United States and/or the named states and/or cities may seek to intervene in the action at a later time. On September 4, 2014, the Company’s motion to dismiss the complaint was granted in part and denied in part. The Company intends to vigorously defend itself in the litigation. The Company does not believe a loss is probable related to the above litigation. Further a reasonable estimate of a possible range of loss cannot be made. In the event that one or more of these matters is unfavorably resolved, it is possible the Company’s results from operations could be materially impacted. In 2012, the Company received subpoenas from the United States Attorney’s Office for the Southern District of Indiana (the “USAO”) and from the Office of Foreign Assets Control of the United States Department of the Treasury (“OFAC”) requesting documents and information related to compliance with export controls and economic sanctions regulations by certain of its subsidiaries. The Company has voluntarily contacted OFAC and the Bureau of Industry and Security of the United States Department of Commerce (“BIS”), in connection with these matters as well as regarding compliance with export controls and economic sanctions regulations by certain other business units of the Company identified in connection with an internal review by the Company. In August 2014, the Company entered into a tolling agreement with OFAC, under which the statute of limitations for any violations by the Company is tolled until September 1, 2015. The Company is cooperating with the USAO, OFAC and BIS with respect to these matters. At this stage of the inquiries, the Company is unable to predict the ultimate outcome of these matters or what impact, if any, the outcome of these matters might have on the Company’s consolidated financial position, results of operations or cash flows. Violations of export control or economic sanctions laws or regulations could result in a range of governmental enforcement actions, including fines or penalties, injunctions and/or criminal or other civil proceedings, which actions could have a material adverse effect on the Company’s reputation, business, financial condition and results of operations. At this time, no claims have been made against the Company. In addition to the matters disclosed above, the Company is, from time to time, subject to a variety of litigation and similar proceedings incidental to its business. These legal matters primarily involve claims for damages arising out of the use of the Company’s products and services and claims relating to intellectual property matters including patent infringement, employment matters, tax matters, commercial disputes, competition and sales and trading practices, personal injury and insurance coverage. The Company may also become subject to lawsuits as a result of past or future acquisitions or as a result of liabilities retained from, representations, warranties or indemnities provided in connection with, divested businesses. Some of these lawsuits may include claims for punitive and consequential, as well as compensatory damages. Based upon the Company’s experience, current information and applicable law, it does not believe that these proceedings and claims will have a material adverse effect on its consolidated results of operations, financial position or liquidity. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to the Company’s business, financial condition, results of operations or liquidity. While the Company maintains general, products, property, workers’ compensation, automobile, cargo, aviation, crime, fiduciary and directors’ and officers’ liability insurance up to certain limits that cover certain of these claims, this insurance may be insufficient or unavailable to cover such losses. In addition, while the Company believes it is entitled to indemnification from third parties for some of these claims, these rights may also be insufficient or unavailable to cover such losses. Purchase Commitments From time to time, the Company enters into long-term inventory purchase commitments with minimum purchase requirements for raw materials and finished goods to ensure the availability of products for production and distribution. These commitments may have a significant impact on levels of inventory maintained by the Company.

SIGNIFICANT ACCOUNTING POLICI24

SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Accounts and Notes Receivable-Trade	The Company records a provision for doubtful accounts, which is included in “Selling, general and administrative expenses” in the Consolidated Statements of Operations. Accounts and notes receivables – trade, net are stated net of allowances for doubtful accounts and trade discounts, which were $ 9.2 million a t June 30, 2015 and $ 8.8 million at December 31, 2014 .
New Accounting Pronouncements, Policy	In April 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” This newly issued accounting standard changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. This standard will have the impact of reducing the frequency of disposals reported as discontinued operations, by requiring such a disposal to represent a strategic shift that has or will have a major effect on entity’s operations and financial results. Additionally, existing provisions that prohibit an entity from reporting a discontinued operation if it has certain continuing cash flows or involvement with the component after a disposal are eliminated by this standard. The ASU also expands the disclosures for discontinued operations and requires new disclosures related to individually significant disposals that do not qualify as discontinued operations. This Company adopted this accounting standard for the quarter ended March 31, 2015. The adoption of this standard did not materially impact the Company’s financial position or results of operations. In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” that seeks to provide a single, comprehensive revenue recognition model for all contracts with customers that improve comparability within industries, across industries and across capital markets. Under this standard, an entity should recognize revenue for the transfer of goods or services equal to the amount it expects to be entitled to receive for those goods or services. Enhanced disclosure requirements regarding the nature, timing and uncertainty of revenue and related cash flows exist. To assist entities in applying the standard, a five step model for recognizing and measuring revenue from contracts with customers has been introduced. Entities have the option to apply the new guidance retrospectively to each prior reporting period presented (full retrospective approach) or retrospectively with a cumulative effect adjustment to retained earnings for initial application of the guidance at the date of initial adoption (modified retrospective method). The Company expects to adopt this accounting standard for the quarter ended March 31, 2017. Early adoption is not permitted. On April 1, 2015, the FASB proposed deferring the effective date by one year to annual reporting periods beginning after December 15, 2017. The proposal has not been ratified. The Company is currently assessing the impact that ASU No. 2014-09 may have on their financial positions, results of operations, cash flows and disclosures, as well as, the transition method they will use to adopt the guidance In January 2015, the FASB issued ASU No. 2015-01, “Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items” This newly issued accounting standard eliminates from generally accepted accounting principles the concept of Extraordinary items, events or transactions that are unusual in nature and occur infrequently. The amendments in this update are effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2015. Prospective application and early adoption is permitted. The adoption of this standard is not expected to impact the Company’s financial position or results of operations. In April 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs.” This newly issued accounting standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct reduction from the carrying amount of that debt liability. Retrospective application is required. The amendments in this standard are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted. The Company adopted this standard during the second quarter of 2015, applying retrospective application to the periods presented in this Form 10-Q. The following is a summary of the adjustment to the financial statement line items impacted by this accounting update: December 31, 2014 (in thousands) As Reported Consolidated Balance Sheet Line Item Balance Adjustment Adjusted Balance Other noncurrent assets, net $ 94,271 (3,806 ) $ 90,465 Notes payable and current portion of long-term debt 112,831 (1,008 ) 111,823 Long-term debt 1,152,882 (2,798 ) 1,150,084 March 31, 2015 (in thousands) As Reported Consolidated Balance Sheet Line Item Balance Adjustment Adjusted Balance Other noncurrent assets, net $ 61,254 (3,568 ) $ 57,686 Notes payable and current portion of long-term debt 247,631 (948 ) 246,683 Long-term debt 1,078,823 (2,620 ) 1,076,203
Description of New Accounting Pronouncements Not yet Adopted	In April 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” This newly issued accounting standard changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. This standard will have the impact of reducing the frequency of disposals reported as discontinued operations, by requiring such a disposal to represent a strategic shift that has or will have a major effect on entity’s operations and financial results. Additionally, existing provisions that prohibit an entity from reporting a discontinued operation if it has certain continuing cash flows or involvement with the component after a disposal are eliminated by this standard. The ASU also expands the disclosures for discontinued operations and requires new disclosures related to individually significant disposals that do not qualify as discontinued operations. This Company adopted this accounting standard for the quarter ended March 31, 2015. The adoption of this standard did not materially impact the Company’s financial position or results of operations. In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” that seeks to provide a single, comprehensive revenue recognition model for all contracts with customers that improve comparability within industries, across industries and across capital markets. Under this standard, an entity should recognize revenue for the transfer of goods or services equal to the amount it expects to be entitled to receive for those goods or services. Enhanced disclosure requirements regarding the nature, timing and uncertainty of revenue and related cash flows exist. To assist entities in applying the standard, a five step model for recognizing and measuring revenue from contracts with customers has been introduced. Entities have the option to apply the new guidance retrospectively to each prior reporting period presented (full retrospective approach) or retrospectively with a cumulative effect adjustment to retained earnings for initial application of the guidance at the date of initial adoption (modified retrospective method). The Company expects to adopt this accounting standard for the quarter ended March 31, 2017. Early adoption is not permitted. On April 1, 2015, the FASB proposed deferring the effective date by one year to annual reporting periods beginning after December 15, 2017. The proposal has not been ratified. The Company is currently assessing the impact that ASU No. 2014-09 may have on their financial positions, results of operations, cash flows and disclosures, as well as, the transition method they will use to adopt the guidance In January 2015, the FASB issued ASU No. 2015-01, “Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items” This newly issued accounting standard eliminates from generally accepted accounting principles the concept of Extraordinary items, events or transactions that are unusual in nature and occur infrequently. The amendments in this update are effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2015. Prospective application and early adoption is permitted. The adoption of this standard is not expected to impact the Company’s financial position or results of operations. In April 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs.” This newly issued accounting standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct reduction from the carrying amount of that debt liability. Retrospective application is required. The amendments in this standard are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted. The Company adopted this standard during the second quarter of 2015, applying retrospective application to the periods presented in this Form 10-Q. The following is a summary of the adjustment to the financial statement line items impacted by this accounting update: December 31, 2014 (in thousands) As Reported Consolidated Balance Sheet Line Item Balance Adjustment Adjusted Balance Other noncurrent assets, net $ 94,271 (3,806 ) $ 90,465 Notes payable and current portion of long-term debt 112,831 (1,008 ) 111,823 Long-term debt 1,152,882 (2,798 ) 1,150,084 March 31, 2015 (in thousands) As Reported Consolidated Balance Sheet Line Item Balance Adjustment Adjusted Balance Other noncurrent assets, net $ 61,254 (3,568 ) $ 57,686 Notes payable and current portion of long-term debt 247,631 (948 ) 246,683 Long-term debt 1,078,823 (2,620 ) 1,076,203

SIGNIFICANT ACCOUNTING POLICI25

SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
New Accounting Pronouncement, Early Adoption	The following is a summary of the adjustment to the financial statement line items impacted by this accounting update: December 31, 2014 (in thousands) As Reported Consolidated Balance Sheet Line Item Balance Adjustment Adjusted Balance Other noncurrent assets, net $ 94,271 (3,806 ) $ 90,465 Notes payable and current portion of long-term debt 112,831 (1,008 ) 111,823 Long-term debt 1,152,882 (2,798 ) 1,150,084 March 31, 2015 (in thousands) As Reported Consolidated Balance Sheet Line Item Balance Adjustment Adjusted Balance Other noncurrent assets, net $ 61,254 (3,568 ) $ 57,686 Notes payable and current portion of long-term debt 247,631 (948 ) 246,683 Long-term debt 1,078,823 (2,620 ) 1,076,203

Stock Compensation (Tables)

Stock Compensation (Tables)	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Stock Based Compensation	The following table represents total stock based compensation expense for non-qualified stock options, restricted stock units (“RSU”) and the tax related benefit for the three and six months ended June 30, 2015 and 2014 : Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Stock option expense $ 2,330 $ 2,829 $ 3,775 $ 4,503 RSU expense 4,272 4,366 7,408 8,085 Total stock based compensation expense $ 6,602 $ 7,195 $ 11,183 $ 12,588 Total related tax benefit $ 1,838 $ 1,979 $ 3,385 $ 3,543

Comprehensive Income (Tables)

Comprehensive Income (Tables)	6 Months Ended
	Jun. 30, 2015
COMPREHENSIVE INCOME [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	Changes in AOCI, net of tax, by component for the six months ended June 30, 2015 and 2014 : (in thousands) Foreign Currency Translation Adjustments Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges Gain and (Loss) on Derivative Financial Instruments Designated as Net Investment Hedges Net Unrealized Holding Gain (Loss) on Available-for-Sale Securities Pension Liability Adjustments Total Balance at December 31, 2014 $ (212,490 ) $ (10,825 ) $ (112,728 ) $ 8,481 $ (113,574 ) $ (441,136 ) Other comprehensive income (loss) before reclassifications (114,891 ) 18,446 (2,345 ) 70,267 — (28,523 ) Amounts reclassified from accumulated other comprehensive income (loss) — (8,173 ) — — 2,826 (5,347 ) Net (decrease) increase in other comprehensive income (114,891 ) 10,273 (2,345 ) 70,267 2,826 (33,870 ) Balance at June 30, 2015 $ (327,381 ) $ (552 ) $ (115,073 ) $ 78,748 $ (110,748 ) $ (475,006 ) (in thousands) Foreign Currency Translation Adjustments Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges Gain and (Loss) on Derivative Financial Instruments Designated as Net Investment Hedges Net Unrealized Holding Gain (Loss)on Available-for-Sale Securities Pension Liability Adjustments Total Balance at December 31, 2013 $ 140,992 $ (21,753 ) $ (151,114 ) $ 12,729 $ (49,916 ) $ (69,062 ) Other comprehensive income (loss) before reclassifications (22,942 ) (2,717 ) 849 (3,803 ) 197 (28,416 ) Amounts reclassified from accumulated other comprehensive income (loss) — 4,065 — — 944 5,009 Net (decrease) increase in other comprehensive income (22,942 ) 1,348 849 (3,803 ) 1,141 (23,407 ) Foreign currency translation related to acquisition of noncontrolling interests (5,530 ) — — — — (5,530 ) Balance at June 30, 2014 $ 112,520 $ (20,405 ) $ (150,265 ) $ 8,926 $ (48,775 ) $ (97,999 )
Reclassification out of Accumulated Other Comprehensive Income	Reclassifications out of accumulated other comprehensive income (expense) to the Consolidated Statements of Operations for the three and six months ended June 30, 2015 and 2014 : (in thousands) Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item in the Statements of Operations Three Months Ended June 30, 2015 2014 Gains and (losses) on derivative financial instruments: Interest rate swaps $ (1,074 ) $ (929 ) Interest expense Foreign exchange forward contracts 6,839 (1,651 ) Cost of products sold Foreign exchange forward contracts 181 (58 ) SG&A expenses Commodity contracts (121 ) (158 ) Cost of products sold 5,825 (2,796 ) Net gain (loss) before tax (1,189 ) 819 Tax (expense) benefit $ 4,636 $ (1,977 ) Net of tax Amortization of defined benefit pension and other postemployment benefit items: Amortization of prior service benefits $ 34 $ 35 (a) Amortization of net actuarial losses (2,015 ) (721 ) (a) (1,981 ) (686 ) Net loss before tax 572 213 Tax benefit $ (1,409 ) $ (473 ) Net of tax Total reclassifications for the period $ 3,227 $ (2,450 ) (a) These accumulated other comprehensive income components are included in the computation of net periodic benefit cost for the three months ended June 30, 2015 and 2014 (see Note 8 , Benefit Plans, for additional details).

EARNINGS PER COMMON SHARE (Tabl

EARNINGS PER COMMON SHARE (Tables)	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Common Share	The following table sets forth the computation of basic and diluted earnings per common share for the three and six months ended June 30, 2015 and 2014 : Basic Earnings Per Common Share Computation Three Months Ended Six Months Ended (in thousands, except per share amounts) 2015 2014 2015 2014 Net income attributable to DENTSPLY International $ 44,099 $ 89,993 $ 108,061 $ 162,871 Weighted average common shares outstanding 139,813 141,790 140,054 141,921 Earnings per common share - basic $ 0.32 $ 0.63 $ 0.77 $ 1.15 Diluted Earnings Per Common Share Computation (in thousands, except per share amounts) Net income attributable to DENTSPLY International $ 44,099 $ 89,993 $ 108,061 $ 162,871 Weighted average common shares outstanding 139,813 141,790 140,054 141,921 Incremental weighted average shares from assumed exercise of dilutive options from stock-based compensation awards 2,449 2,374 2,467 2,367 Total weighted average diluted shares outstanding 142,262 144,164 142,521 144,288 Earnings per common share - diluted $ 0.31 $ 0.62 $ 0.76 $ 1.13

SEGMENT AND GEOGRAPHIC INFORM29

SEGMENT AND GEOGRAPHIC INFORMATION (Tables)	6 Months Ended
	Jun. 30, 2015
Segment Reporting [Abstract]
Net Sales	The following tables set forth information about the Company’s segments for the three and six months ended June 30, 2015 and 2014 : Third Party Net Sales Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 317,376 $ 346,264 $ 627,693 $ 685,545 Healthcare, Orthodontic and Implant Businesses 252,845 279,696 488,838 544,107 Select Developed and Emerging Markets Businesses 127,785 139,265 237,795 265,687 Total net sales $ 698,006 $ 765,225 $ 1,354,326 $ 1,495,339
Net Sales, Excluding Precious Metal Content	Third Party Net Sales, Excluding Precious Metal Content Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 301,299 $ 319,978 $ 593,390 $ 625,050 Healthcare, Orthodontic and Implant Businesses 252,665 279,478 488,476 543,681 Select Developed and Emerging Markets Businesses 120,734 131,442 224,379 251,350 Total net sales, excluding precious metal content 674,698 730,898 1,306,245 1,420,081 Precious metal content of sales 23,308 34,327 48,081 75,258 Total net sales, including precious metal content $ 698,006 $ 765,225 $ 1,354,326 $ 1,495,339
Intersegment Net Sales	Inter-segment Net Sales Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2,014 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 89,324 $ 93,642 $ 173,213 $ 183,100 Healthcare, Orthodontic and Implant Businesses 1,578 1,970 3,352 4,431 Select Developed and Emerging Markets Businesses 3,437 2,722 6,313 6,239 All Other (a) 67,116 75,860 132,166 150,482 Eliminations (161,455 ) (174,194 ) (315,044 ) (344,252 ) Total $ — $ — $ — $ — (a) Includes amounts recorded at one distribution warehouse not managed by named segments.
Segment Operating Income	Segment Operating Income (Loss) Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 110,787 $ 117,976 $ 214,193 $ 224,745 Healthcare, Orthodontic and Implant Businesses 27,906 32,049 54,435 56,574 Select Developed and Emerging Markets Businesses (3,464 ) (1,211 ) (7,350 ) (2,503 ) Segment operating income 135,229 148,814 261,278 278,816 Reconciling Items (income) expense: All Other (b) 10,547 20,466 33,461 44,105 Restructuring and other costs 38,881 1,242 44,307 2,035 Interest expense 9,824 11,798 20,492 22,753 Interest income (660 ) (1,744 ) (1,402 ) (3,179 ) Other expense (income), net (376 ) 575 232 963 Income before income taxes $ 77,013 $ 116,477 $ 164,188 $ 212,139 (b) Includes the results of unassigned Corporate headquarter costs, inter-segment eliminations and one distribution warehouse not managed by named segments.
Assets	Assets (in thousands) June 30, 2015 December 31, 2014 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 1,360,187 $ 1,358,018 Healthcare, Orthodontic and Implant Businesses 2,508,278 2,655,622 Select Developed and Emerging Markets Businesses 352,866 369,844 All Other (c) 275,425 262,975 Total $ 4,496,756 $ 4,646,459 (c) Includes the assets of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segments.

INVENTORIES (Tables)

INVENTORIES (Tables)	6 Months Ended
	Jun. 30, 2015
Inventory Disclosure [Abstract]
Inventories, net	Inventories, net of inventory valuation reserves, consist of the following: (in thousands) June 30, 2015 December 31, 2014 Finished goods $ 242,921 $ 253,333 Work-in-process 59,858 58,329 Raw materials and supplies 72,041 75,433 Inventories, net $ 374,820 $ 387,095

BENEFIT PLANS (Tables)

BENEFIT PLANS (Tables)	6 Months Ended
	Jun. 30, 2015
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
Components of Net Periodic Benefit Cost	The following sets forth the components of net periodic benefit cost of the Company’s defined benefit plans and for the Company’s other postemployment benefit plans for the three and six months ended June 30, 2015 and 2014 : Defined Benefit Plans Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Service cost $ 4,343 $ 3,549 $ 8,691 $ 7,101 Interest cost 1,843 2,861 3,697 5,726 Expected return on plan assets (1,399 ) (1,391 ) (2,777 ) (2,777 ) Amortization of prior service credit (35 ) (35 ) (69 ) (69 ) Amortization of net actuarial loss 1,963 709 3,947 1,417 Net periodic benefit cost $ 6,715 $ 5,693 $ 13,489 $ 11,398 Other Postemployment Benefit Plans Three Months Ended Six Months Ended (in thousands) 2015 2014 2015 2014 Service cost $ 88 $ 44 $ 177 $ 89 Interest cost 144 140 288 280 Amortization of net actuarial loss 43 12 85 22 Net periodic benefit cost $ 275 $ 196 $ 550 $ 391
Information Related to the Contributions to the Compnay's Benefit Plans	The following sets forth the information related to the contributions to the Company’s benefit plans for 2015 : (in thousands) Pension Benefits Other Postemployment Benefits Actual contributions through June 30, 2015 $ 5,559 $ 192 Projected contributions for the remainder of the year 5,945 449 Total projected contributions $ 11,504 $ 641

RESTRUCTURING AND OTHER COSTS (

RESTRUCTURING AND OTHER COSTS (Tables)	6 Months Ended
	Jun. 30, 2015
Restructuring and Related Activities [Abstract]
Restructuring Accruals	At June 30, 2015 , the Company’s restructuring accruals were as follows: Severance (in thousands) 2013 and Prior Plans 2014 Plans 2015 Plans Total Balance at December 31, 2014 $ 951 $ 5,062 $ — $ 6,013 Provisions 81 431 40,958 41,470 Amounts applied (635 ) (3,084 ) (3,542 ) (7,261 ) Change in estimates (76 ) (74 ) (547 ) (697 ) Balance at June 30, 2015 $ 321 $ 2,335 $ 36,869 $ 39,525 Lease/Contract Terminations (in thousands) 2013 and Prior Plans 2014 Plans 2015 Plans Total Balance at December 31, 2014 $ 535 $ 1,636 $ — $ 2,171 Provisions — 12 270 282 Amounts applied (105 ) (384 ) — (489 ) Change in estimates — (10 ) — (10 ) Balance at June 30, 2015 $ 430 $ 1,254 $ 270 $ 1,954 Other Restructuring Costs (in thousands) 2013 and Prior Plans 2014 Plans 2015 Plans Total Balance at December 31, 2014 $ 25 $ 1,049 $ — $ 1,074 Provisions 2 168 577 747 Amounts applied (2 ) (799 ) (227 ) (1,028 ) Change in estimate — 28 — 28 Balance at June 30, 2015 $ 25 $ 446 $ 350 $ 821
Cumulative Amounts for the Provisions and Adjustments and Amounts Applied for All the Plans by Segment	The following table provides the year-to-date changes in the restructuring accruals by segment: (in thousands) December 31, 2014 Provisions Amounts Applied Change in Estimates June 30, 2015 Dental Consumables, Endodontic and Dental Laboratory Businesses $ 5,272 $ 31,522 $ (3,941 ) $ — $ 32,853 Healthcare, Orthodontic and Implant Businesses 3,828 7,517 (4,558 ) (679 ) 6,108 Select Developed and Emerging Markets Businesses 91 1,719 (177 ) — 1,633 All Other 67 1,741 (102 ) — 1,706 Total $ 9,258 $ 42,499 $ (8,778 ) $ (679 ) $ 42,300

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities (Tables)	6 Months Ended
	Jun. 30, 2015
Derivative [Line Items]
Schedule of Derivative Instruments	The following table summarizes the notional amounts of hedges of net investments by derivative instrument type at June 30, 2015 and the notional amounts expected to mature during the next 12 months: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in thousands) Foreign exchange forward contracts $ 420,892 $ 236,079 The following table summarizes the notional amounts of cash flow hedges by derivative instrument type at June 30, 2015 and the notional amounts expected to mature during the next 12 months, with a discussion of the various cash flow hedges by derivative instrument type following the table: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in thousands) Foreign exchange forward contracts $ 337,017 $ 253,842 Interest rate swaps 172,169 — Commodity contracts 1,396 1,396 Total derivative instruments designated as cash flow hedges $ 510,582 $ 255,238
Derivative Instruments, Gain (Loss)	The following table summarizes the amounts of gains (losses) recorded on the Company’s Consolidated Statements of Operations related to the economic hedges not designated as hedging for the three and six months ended June 30, 2015 and 2014 : Consolidated Statements of Operations Location Gain (Loss) Recognized Three Months Ended June 30, (in thousands) 2015 2014 Foreign exchange forward contracts (a) Other expense (income), net $ (766 ) $ (716 ) DIO equity option contracts Other expense (income), net 102 90 Interest rate swaps Interest expense 1 (16 ) Cross currency basis swaps (a) Other expense (income), net (603 ) (4,005 ) Total for instruments not designated as hedges $ (1,266 ) $ (4,647 )
Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]	The following tables summarize the aggregate notional amounts of the Company’s economic hedges not designated as hedges by derivative instrument types at June 30, 2015 and the notional amounts expected to mature during the next 12 months: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in thousands) Foreign exchange forward contracts $ 478,338 $ 478,338 Interest rate swaps 2,213 805 Total for instruments not designated as hedges $ 480,551 $ 479,143
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The following tables summarize the fair value and consolidated balance sheet location of the Company’s derivatives at June 30, 2015 and December 31, 2014 : June 30, 2015 (in thousands) Prepaid Expenses and Other Current Assets, Net Other Noncurrent Assets, Net Accrued Liabilities Other Noncurrent Liabilities Designated as Hedges Foreign exchange forward contracts $ 32,398 $ 1,833 $ 1,490 $ 2,675 Commodity contracts — — 152 — Interest rate swaps 324 282 1,164 742 Total $ 32,722 $ 2,115 $ 2,806 $ 3,417 Not Designated as Hedges Foreign exchange forward contracts $ 7,273 $ — $ 3,465 $ — Interest rate swaps — — 51 77 Total $ 7,273 $ — $ 3,516 $ 77 December 31, 2014 (in thousands) Prepaid Other Noncurrent Assets, Net Accrued Liabilities Other Noncurrent Liabilities Designated as Hedges Foreign exchange forward contracts $ 28,036 $ 12,542 $ 2,740 $ 1,707 Commodity contracts — — 233 — Interest rate swaps 617 135 575 377 Total $ 28,653 $ 12,677 $ 3,548 $ 2,084 Not Designated as Hedges Foreign exchange forward contracts $ 4,798 $ — $ 4,764 $ — DIO equity option contracts — — — 115 Interest rate swaps — — 63 129 Cross currency basis swaps 2,683 — — — Total $ 7,481 $ — $ 4,827 $ 244
Offsetting Derivative Assets and Liabilities	Offsetting of financial assets and liabilities under netting arrangements at June 30, 2015 : Gross Amounts Not Offset in the Consolidated Balance Sheets (in thousands) Gross Amounts Recognized Gross Amount Offset in the Consolidated Balance Sheets Net Amounts Presented in the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Assets Foreign exchange forward contracts $ 41,504 $ — $ 41,504 $ (9,363 ) $ — $ 32,141 Interest rate swaps 606 — 606 (173 ) — 433 Total Assets $ 42,110 $ — $ 42,110 $ (9,536 ) $ — $ 32,574 Gross Amounts Not Offset in the Consolidated Balance Sheets (in thousands) Gross Amounts Recognized Gross Amount Offset in the Consolidated Balance Sheets Net Amounts Presented in the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Liabilities Foreign exchange forward contracts $ 7,630 $ — $ 7,630 $ (7,630 ) $ — $ — Commodity contracts 152 — 152 — — 152 Interest rate swaps 2,034 — 2,034 (1,906 ) — 128 Total Liabilities $ 9,816 $ — $ 9,816 $ (9,536 ) $ — $ 280 Offsetting of financial assets and liabilities under netting arrangements at December 31, 2014 : Gross Amounts Not Offset in the Consolidated Balance Sheets (in thousands) Gross Amounts Recognized Gross Amount Offset in the Consolidated Balance Sheets Net Amounts Presented in the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Assets Foreign exchange forward contracts $ 45,377 $ — $ 45,377 $ (7,797 ) $ — $ 37,580 Interest rate swaps 751 — 751 (274 ) — 477 Cross currency basis swaps 2,683 — 2,683 (1,067 ) — 1,616 Total Assets $ 48,811 $ — $ 48,811 $ (9,138 ) $ — $ 39,673 Gross Amounts Not Offset in the Consolidated Balance Sheets (in thousands) Gross Amounts Recognized Gross Amount Offset in the Consolidated Balance Sheets Net Amounts Presented in the Consolidated Balance Sheets Financial Instruments Cash Collateral Received/Pledged Net Amount Liabilities Foreign exchange forward contracts $ 9,208 $ — $ 9,208 $ (8,186 ) $ — $ 1,022 Commodity contracts 235 — 235 — — 235 DIO equity option contracts 115 — 115 — — 115 Interest rate swaps 1,145 — 1,145 (952 ) — 193 Total Liabilities $ 10,703 $ — $ 10,703 $ (9,138 ) $ — $ 1,565
Cash Flow Hedging
Derivative [Line Items]
Schedule of Derivative Instruments	The following tables summarize the amount of gains (losses) recorded in AOCI in the Consolidated Balance Sheets and income (expense) in the Company’s Consolidated Statements of Operations related to all cash flow hedges for the three months ended June 30, 2015 and 2014 : June 30, 2015 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in thousands) Effective Portion: Interest rate swaps $ (58 ) Interest expense $ (1,074 ) $ — Foreign exchange forward contracts (2,069 ) Cost of products sold 6,839 — Foreign exchange forward contracts (139 ) SG&A expenses 181 — Commodity contracts (96 ) Cost of products sold (121 ) — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (160 ) Commodity contracts — Interest expense — (4 ) Total in cash flow hedging $ (2,362 ) $ 5,825 $ (164 ) June 30, 2014 Gain (Loss) in AOCI Consolidated Statements of Operations Location Effective Portion Reclassified from AOCI into Income (Expense) Ineffective Portion Recognized in Income (Expense) (in thousands) Effective Portion: Interest rate swaps $ (149 ) Interest expense $ (929 ) $ — Foreign exchange forward contracts (4,636 ) Cost of products sold (1,651 ) — Foreign exchange forward contracts 45 SG&A expenses (58 ) — Commodity contracts 101 Cost of products sold (158 ) — Ineffective Portion: Foreign exchange forward contracts — Other expense (income), net — (151 ) Commodity contracts — Interest expense — (11 ) Total for cash flow hedging $ (4,639 ) $ (2,796 ) $ (162 )
Net Investment Hedging
Derivative [Line Items]
Schedule of Derivative Instruments	The following tables summarize the amount of gains (losses) recorded in AOCI on the Consolidated Balance Sheets and other income (expense) on the Company’s Consolidated Statements of Operations related to the hedges of net investments for the three months ended June 30, 2015 and 2014 : June 30, 2015 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in thousands) Effective Portion: Foreign exchange forward contracts $ (15,819 ) Other expense (income), net $ 1,191 Total for net investment hedging $ (15,819 ) $ 1,191 June 30, 2014 Gain (Loss) in AOCI Consolidated Statements of Operations Location Recognized in Income (Expense) (in thousands) Effective Portion: Cross currency basis swaps $ 1,572 Interest income $ 674 Interest expense (384 ) Foreign exchange forward contracts 1,272 Other expense (income), net (73 ) Total for net investment hedging $ 2,844 $ 217
Fair Value Hedging
Derivative [Line Items]
Schedule of Derivative Instruments	The following table summarizes the notional amounts of fair value hedges by derivative instrument type at June 30, 2015 and the notional amounts expected to mature during the next 12 months: Aggregate Notional Amount Aggregate Notional Amount Maturing within 12 Months (in thousands) Interest rate swaps $ 45,000 $ 45,000
Derivative Instruments, Gain (Loss)	The following tables summarize the amount of income (expense) recorded on the Company’s Consolidated Statements of Operations related to the hedges of fair value for the three and six months ended June 30, 2015 and 2014 : Consolidated Statements of Operations Location Three Months Ended June 30, Six Months Ended June 30, (in thousands) 2015 2014 2015 2014 Interest rate swaps Interest expense $ 41 $ 133 $ 158 $ 220

FAIR VALUE MEASUREMENT (Tables)

FAIR VALUE MEASUREMENT (Tables)	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities that are Recorded at Fair Value and Classified Based on the Lowest Level of Input	The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis at June 30, 2015 and December 31, 2014 , which are classified as “Cash and cash equivalents,” “Prepaid expenses and other current assets, net,” “Other noncurrent assets, net,” “Accrued liabilities,” and “Other noncurrent liabilities” in the Consolidated Balance Sheets. Financial assets and liabilities that are recorded at fair value as of the balance sheet date are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. June 30, 2015 (in thousands) Total Level 1 Level 2 Level 3 Assets Interest rate swaps $ 606 $ — $ 606 $ — Foreign exchange forward contracts 41,504 — 41,504 — DIO Corporation convertible bonds 153,613 — — 153,613 Total assets $ 195,723 $ — $ 42,110 $ 153,613 Liabilities Interest rate swaps $ 2,034 $ — $ 2,034 $ — Commodity contracts 152 — 152 — Foreign exchange forward contracts 7,630 — 7,630 — Long-term debt 45,326 — 45,326 — Total liabilities $ 55,142 $ — $ 55,142 $ — December 31, 2014 (in thousands) Total Level 1 Level 2 Level 3 Assets Interest rate swaps $ 752 $ — $ 752 $ — Cross currency basis swaps 2,683 — 2,683 — Foreign exchange forward contracts 45,376 — 45,376 — DIO Corporation convertible bonds 57,698 — — 57,698 Total assets $ 106,509 $ — $ 48,811 $ 57,698 Liabilities Interest rate swaps $ 1,144 $ — $ 1,144 $ — Commodity contracts 233 — 233 — Foreign exchange forward contracts 9,211 — 9,211 — Long-term debt 106,023 — 106,023 — DIO equity option contracts 115 — — 115 Total liabilities $ 116,726 $ — $ 116,611 $ 115
Reconciliation of the Company's Assets Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)	The following table presents a rollforward of the Company’s Level 3 holdings measured at fair value on a recurring basis using unobservable inputs: (in thousands) DIO Corporation Convertible Bonds DIO Equity Options Contracts Balance at December 31, 2014 $ 57,698 $ (115 ) Unrealized gain: Reported in AOCI, pretax 101,351 — Unrealized gain: Reported in other expense (income), net — 107 Effects of exchange rate changes (5,436 ) 8 Balance at June 30, 2015 $ 153,613 $ —

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	6 Months Ended
	Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Changes In Goodwill Table Text Block	A reconciliation of changes in the Company’s goodwill is as follows: (in thousands) Dental Consumables, Endodontic and Dental Laboratory Businesses Healthcare, Orthodontic and Implant Businesses Select Developed and Emerging Markets Businesses Total Balance at December 31, 2014 $ 565,714 $ 1,394,398 $ 129,227 $ 2,089,339 Effects of exchange rate changes (6,268 ) (76,509 ) (7,954 ) (90,731 ) Balance at June 30, 2015 $ 559,446 $ 1,317,889 $ 121,273 $ 1,998,608
Reconciliation of Changes in the Company's Goodwill	Identifiable definite-lived and indefinite-lived intangible assets consist of the following: June 30, 2015 December 31, 2014 (in thousands) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Patents $ 165,615 $ (91,135 ) $ 74,480 $ 175,186 $ (95,526 ) $ 79,660 Trademarks 68,271 (38,027 ) 30,244 75,645 (37,053 ) 38,592 Licensing agreements 34,071 (23,629 ) 10,442 34,638 (22,806 ) 11,832 Customer relationships 433,627 (114,086 ) 319,541 452,882 (104,703 ) 348,179 Total definite-lived $ 701,584 $ (266,877 ) $ 434,707 $ 738,351 $ (260,088 ) $ 478,263 Indefinite-lived Trademarks and In-process R&D $ 181,962 $ — $ 181,962 $ 192,577 $ — $ 192,577 Total identifiable intangible assets $ 883,546 $ (266,877 ) $ 616,669 $ 930,928 $ (260,088 ) $ 670,840

SIGNIFICANT ACCOUNTING POLICI36

SIGNIFICANT ACCOUNTING POLICIES Additional Information (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014
Significant Accounting Policies [Line Items]
Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax	$ 70,300		$ 8,500
Other noncurrent assets, net	43,113		90,465
Notes payable and current portion of long-term debt	119,704		111,823
Long-term debt	1,077,779		1,150,084
Corporate Bond Securities
Significant Accounting Policies [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	153,613		57,698
Trade Accounts Receivable
Significant Accounting Policies [Line Items]
Allowance for Doubtful Accounts Receivable, Current	$ 9,200		8,800
Adjustments for New Accounting Principle, Early Adoption [Member]
Significant Accounting Policies [Line Items]
Other noncurrent assets, net		$ 57,686	90,465
Notes payable and current portion of long-term debt		246,683	111,823
Long-term debt		1,076,203	1,150,084
Scenario, Previously Reported | Adjustments for New Accounting Principle, Early Adoption [Member]
Significant Accounting Policies [Line Items]
Other noncurrent assets, net		61,254	94,271
Notes payable and current portion of long-term debt		247,631	112,831
Long-term debt		1,078,823	1,152,882
Restatement Adjustment | Adjustments for New Accounting Principle, Early Adoption [Member]
Significant Accounting Policies [Line Items]
Other noncurrent assets, net		(3,568)	(3,806)
Notes payable and current portion of long-term debt		(948)	(1,008)
Long-term debt		$ (2,620)	$ (2,798)

STOCK COMPENSATION Stock Compen

STOCK COMPENSATION Stock Compensation (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2014	Mar. 31, 2014	Jun. 30, 2015	Jun. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 6,602	$ 6,602	$ 7,195	$ 7,195	$ 11,183	$ 12,588
Nonqualified Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unamortized compensation cost	13,700				$ 13,700
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term					1 year 9 months
Performance Based Restricted Stock and Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unamortized compensation cost	26,500				$ 26,500
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 4,272		$ 4,366		$ 7,408	8,085
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term					1 year 6 months
Selling, General and Administrative Expenses
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense		6,400		7,000	$ 10,800	12,200
Cost of Sales
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense		$ 200		$ 200	$ 300	$ 400

STOCK COMPENSATION Total Stock

STOCK COMPENSATION Total Stock Based Compensation Expense and the Tax Related Benefit (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2014	Mar. 31, 2014	Jun. 30, 2015	Jun. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 6,602	$ 6,602	$ 7,195	$ 7,195	$ 11,183	$ 12,588
Total related tax benefit	1,838		1,979		3,385	3,543
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	2,330		2,829		3,775	4,503
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense	$ 4,272		$ 4,366		$ 7,408	$ 8,085

COMPREHENSIVE INCOME Comprehens

COMPREHENSIVE INCOME Comprehensive Income - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2014	Mar. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency translation adjustments	$ 75,972		$ (27,640)		$ (112,932)	$ (28,675)
Accumulated Other Comprehensive Income Loss Foreign Currency Translation Gains Net Of Tax	(230,700)				(230,700)		$ (117,100)
Accumulated Other Comprehensive Income Loss Foreign Currency Translation Losses Net Of Tax	$ (96,700)				(96,700)		$ (95,400)
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency translation adjustments		$ (74,900)		$ (20,600)	(113,700)	(19,700)
Net Investment Hedging | Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax		$ (400)		$ (1,200)	$ (1,200)	$ (3,200)

COMPREHENSIVE INCOME Balances i

COMPREHENSIVE INCOME Balances included in AOCI, Net of Tax, in the Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			$ (441,136)
Net (decrease) increase in other comprehensive income	$ 142,660	$ 62,129	74,191	$ 133,934
Ending balance	(475,006)		(475,006)
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(212,490)	140,992
Other comprehensive income (loss) before reclassifications			(114,891)	(22,942)
Amounts reclassified from accumulated other comprehensive income (loss)			0	0
Net (decrease) increase in other comprehensive income			(114,891)	(22,942)
Foreign currency translation related to acquisition of noncontrolling interests				(5,530)
Ending balance	(327,381)	112,520	(327,381)	112,520
Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(10,825)	(21,753)
Other comprehensive income (loss) before reclassifications			18,446	(2,717)
Amounts reclassified from accumulated other comprehensive income (loss)			(8,173)	4,065
Net (decrease) increase in other comprehensive income			10,273	1,348
Foreign currency translation related to acquisition of noncontrolling interests				0
Ending balance	(552)	(20,405)	(552)	(20,405)
Gain and (Loss) on Derivative Financial Instruments Designated as Net Investment Hedges
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(112,728)	(151,114)
Other comprehensive income (loss) before reclassifications			(2,345)	849
Amounts reclassified from accumulated other comprehensive income (loss)			0	0
Net (decrease) increase in other comprehensive income			(2,345)	849
Foreign currency translation related to acquisition of noncontrolling interests				0
Ending balance	(115,073)	(150,265)	(115,073)	(150,265)
Net Unrealized Holding Gain (Loss) on Available-for-Sale Securities
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			8,481	12,729
Other comprehensive income (loss) before reclassifications			70,267	(3,803)
Amounts reclassified from accumulated other comprehensive income (loss)			0	0
Net (decrease) increase in other comprehensive income			70,267	(3,803)
Foreign currency translation related to acquisition of noncontrolling interests				0
Ending balance	78,748	8,926	78,748	8,926
Pension Liability Adjustments
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(113,574)	(49,916)
Other comprehensive income (loss) before reclassifications			0	197
Amounts reclassified from accumulated other comprehensive income (loss)			2,826	944
Net (decrease) increase in other comprehensive income			2,826	1,141
Foreign currency translation related to acquisition of noncontrolling interests				0
Ending balance	(110,748)	(48,775)	(110,748)	(48,775)
Total DENTSPLY International Equity
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(441,136)	(69,062)
Other comprehensive income (loss) before reclassifications			(28,523)	(28,416)
Amounts reclassified from accumulated other comprehensive income (loss)			(5,347)	5,009
Net (decrease) increase in other comprehensive income			(33,870)	(23,407)
Foreign currency translation related to acquisition of noncontrolling interests				(5,530)
Ending balance	$ (475,006)	$ (97,999)	$ (475,006)	$ (97,999)

COMPREHENSIVE INCOME Reclassifi

COMPREHENSIVE INCOME Reclassification out of Accumulated Other Comprehensive Income (Expense) (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2015		Jun. 30, 2014		Jun. 30, 2015	Jun. 30, 2014
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Provision for income taxes	$ (24,775)		$ (26,096)		$ (43,628)	$ (48,548)
Net Income (Loss) Available to Common Stockholders, Basic	3,227		(2,450)		5,347	(5,009)
Gain and (Loss) on Derivative Financial Instruments Designated as Cash Flow Hedges
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest	5,825		(2,796)		8,780	(5,712)
Provision for income taxes	(1,189)		819		607	(1,647)
Net Income (Loss) Available to Common Stockholders, Basic	4,636		(1,977)		8,173	(4,065)
Pension Liability Adjustments
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax	34	[1]	35	[1]	68	69	[1]
Other Comprehensive Income (Loss) adjustment from AOCI,Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax	(2,015)	[1]	(721)	[1]	(4,041)	(1,439)
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest	(1,981)		(686)		(3,973)	(1,370)
Provision for income taxes	572		213		1,147	426
Net Income (Loss) Available to Common Stockholders, Basic	(1,409)		(473)		(2,826)	(944)
Cash Flow Hedging | Designated as Hedging Instrument
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	5,825		(2,796)		8,780	(5,712)
Interest Expense | Cash Flow Hedging | Designated as Hedging Instrument | Interest Rate Swap
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(1,074)		(929)		(2,040)	(1,856)
Cost of Sales | Cash Flow Hedging | Designated as Hedging Instrument | Foreign Exchange Contract
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	6,839		(1,651)		10,726	(3,296)
Cost of Sales | Cash Flow Hedging | Designated as Hedging Instrument | Commodity Contract
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(121)		(158)		(250)	(403)
Selling, General and Administrative Expenses | Cash Flow Hedging | Designated as Hedging Instrument | Foreign Exchange Contract
Reclassification of Acuumulated Other Comprehensive Income [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ 181		$ (58)		$ 344	$ (157)
[1]	These accumulated other comprehensive income components are included in the computation of net periodic benefit cost for the three months ended June 30, 2015 and 2014 (see Note 8, Benefit Plans, for additional details).

EARNINGS PER COMMON SHARE Addit

EARNINGS PER COMMON SHARE Additional Information (Detail) - Jun. 30, 2015 - shares shares in Millions	Total	Total
Earnings Per Share [Abstract]
Antidilutive common stock options not included in the computation of diluted earnings per common share (in shares)	0.8	1

EARNINGS PER COMMON SHARE Compu

EARNINGS PER COMMON SHARE Computation of Basic and Diluted Earnings Per Common Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Earnings Per Share [Abstract]
Net income attributable to DENTSPLY International	$ 44,099	$ 89,993	$ 108,061	$ 162,871
Shares
Basic	139,813	141,790	140,054	141,921
Incremental shares from assumed exercise of dilutive options from stock-based compensation awards (in shares)	2,449	2,374	2,467	2,367
Diluted (in shares)	142,262	144,164	142,521	144,288
Earnings per common share
Basic (in dollars per share)	$ 0.32	$ 0.63	$ 0.77	$ 1.15
Diluted (in dollars per share)	$ 0.31	$ 0.62	$ 0.76	$ 1.13

BUSINESS COMBINATIONS - Other D

BUSINESS COMBINATIONS - Other Disclosures (Details)	Jan. 01, 2014Entity
Business Combinations [Abstract]
Variable Interest Entity, Number of Entities	1

SEGMENT INFORMATION Additional

SEGMENT INFORMATION Additional Information (Detail)	6 Months Ended
	Jun. 30, 2015
Dental Products
Segment Reporting Information [Line Items]
Percentage of sales, professional dental products	88.00%

SEGMENT INFORMATION Net Sales (

SEGMENT INFORMATION Net Sales (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Net sales	$ 698,006	$ 765,225	$ 1,354,326	$ 1,495,339
Operating Segments | Dental Consumables, Endodontic and Dental Laboratory Businesses
Net sales	317,376	346,264	627,693	685,545
Operating Segments | Healthcare, Orthodontic and Implant Businesses
Net sales	252,845	279,696	488,838	544,107
Operating Segments | Select Developed and Emerging Markets Businesses
Net sales	$ 127,785	$ 139,265	$ 237,795	$ 265,687

SEGMENT INFORMATION Net Sales,

SEGMENT INFORMATION Net Sales, Excluding Precious Metal Content (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenue, Major Customer [Line Items]
Net Sales, excluding precious metal content	$ 674,698	$ 730,898	$ 1,306,245	$ 1,420,081
Precious metal content of sales	23,308	34,327	48,081	75,258
Net Sales, including precious metal content	698,006	765,225	1,354,326	1,495,339
Operating Segments | Dental Consumables, Endodontic and Dental Laboratory Businesses
Revenue, Major Customer [Line Items]
Net Sales, excluding precious metal content	301,299	319,978	593,390	625,050
Net Sales, including precious metal content	317,376	346,264	627,693	685,545
Operating Segments | Healthcare, Orthodontic and Implant Businesses
Revenue, Major Customer [Line Items]
Net Sales, excluding precious metal content	252,665	279,478	488,476	543,681
Net Sales, including precious metal content	252,845	279,696	488,838	544,107
Operating Segments | Select Developed and Emerging Markets Businesses
Revenue, Major Customer [Line Items]
Net Sales, excluding precious metal content	120,734	131,442	224,379	251,350
Net Sales, including precious metal content	$ 127,785	$ 139,265	$ 237,795	$ 265,687

SEGMENT INFORMATION Intersegmen

SEGMENT INFORMATION Intersegment Net Sales (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Segment Reporting, Revenue Reconciling Item [Line Items]
Total		$ 0	$ 0	$ 0	$ 0
Intersegment Eliminations
Segment Reporting, Revenue Reconciling Item [Line Items]
Intersegment Eliminations		(161,455)	(174,194)	(315,044)	(344,252)
Intersegment Eliminations | Dental Consumables, Endodontic and Dental Laboratory Businesses
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues		89,324	93,642	173,213	183,100
Intersegment Eliminations | Healthcare, Orthodontic and Implant Businesses
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues		1,578	1,970	3,352	4,431
Intersegment Eliminations | Select Developed and Emerging Markets Businesses
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues		3,437	2,722	6,313	6,239
Intersegment Eliminations | All Other
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	[1]	$ 67,116	$ 75,860	$ 132,166	$ 150,482
[1]	Includes amounts recorded at one distribution warehouse not managed by named segments.

SEGMENT INFORMATION Segment Ope

SEGMENT INFORMATION Segment Operating Income (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment operating income		$ 85,801	$ 127,106	$ 183,510	$ 232,676
Restructuring and other costs		38,881	1,242	44,307	2,035
Interest expense		9,824	11,798	20,492	22,753
Interest income		(660)	(1,744)	(1,402)	(3,179)
Other expense (income), net		(376)	575	232	963
Income before income taxes		77,013	116,477	164,188	212,139
Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment operating income		135,229	148,814	261,278	278,816
Operating Segments | Dental Consumables, Endodontic and Dental Laboratory Businesses
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment operating income		110,787	117,976	214,193	224,745
Operating Segments | Healthcare, Orthodontic and Implant Businesses
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment operating income		27,906	32,049	54,435	56,574
Operating Segments | Select Developed and Emerging Markets Businesses
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment operating income		(3,464)	(1,211)	(7,350)	(2,503)
Operating Segments | All Other
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment operating income	[1]	$ 10,547	$ 20,466	$ 33,461	$ 44,105
[1]	Includes the results of unassigned Corporate headquarter costs, inter-segment eliminations and one distribution warehouse not managed by named segments.

SEGMENT INFORMATION Assets (Det

SEGMENT INFORMATION Assets (Details) - USD ($) $ in Thousands		Jun. 30, 2015	Dec. 31, 2014
Segment Reporting, Asset Reconciling Item [Line Items]
Assets		$ 4,496,756	$ 4,646,459
Operating Segments | Dental Consumables, Endodontic and Dental Laboratory Businesses
Segment Reporting, Asset Reconciling Item [Line Items]
Assets		1,360,187	1,358,018
Operating Segments | Healthcare, Orthodontic and Implant Businesses
Segment Reporting, Asset Reconciling Item [Line Items]
Assets		2,508,278	2,655,622
Operating Segments | Select Developed and Emerging Markets Businesses
Segment Reporting, Asset Reconciling Item [Line Items]
Assets		352,866	369,844
Operating Segments | All Other
Segment Reporting, Asset Reconciling Item [Line Items]
Assets	[1]	$ 275,425	$ 262,975
[1]	Includes the assets of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segments.

INVENTORIES Additional Informat

INVENTORIES Additional Information (Detail) - USD ($) $ in Millions	Jun. 30, 2015	Dec. 31, 2014
Inventory Disclosure [Abstract]
LIFO inventory amount	$ 7	$ 6.3
Inventory, LIFO reserve	6.2	6.1
Inventory valuation reserve	$ 36.3	$ 34.1

INVENTORIES Inventories (Detail

INVENTORIES Inventories (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Inventory Disclosure [Abstract]
Finished goods	$ 242,921	$ 253,333
Work-in-process	59,858	58,329
Raw materials and supplies	72,041	75,433
Inventory, net	$ 374,820	$ 387,095

BENEFIT PLANS Components of Net

BENEFIT PLANS Components of Net Periodic Benefit Cost (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Pension Plans, Defined Benefit
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost	$ 4,343	$ 3,549	$ 8,691	$ 7,101
Interest cost	1,843	2,861	3,697	5,726
Expected return on plan assets	(1,399)	(1,391)	(2,777)	(2,777)
Amortization of prior service cost	(35)	(35)	(69)	(69)
Amortization of net loss	1,963	709	3,947	1,417
Defined Benefit Plan, Net Periodic Benefit Cost	6,715	5,693	13,489	11,398
Other Postretirement Benefit Plans, Defined Benefit
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost	88	44	177	89
Interest cost	144	140	288	280
Amortization of net loss	43	12	85	22
Defined Benefit Plan, Net Periodic Benefit Cost	$ 275	$ 196	$ 550	$ 391

BENEFIT PLANS Information Relat

BENEFIT PLANS Information Related to the Contributions to the Company's Benefit Plans (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2015USD ($)
Pension Plans, Defined Benefit
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Actual contributions through June 30, 2015	$ 5,559
Projected for the remainder of the year	5,945
Defined Benefit Plan, Expected Contributions in Current Fiscal Year	11,504
Other Postretirement Benefit Plans, Defined Benefit
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Actual contributions through June 30, 2015	192
Projected for the remainder of the year	449
Defined Benefit Plan, Expected Contributions in Current Fiscal Year	$ 641

RESTRUCTURING AND OTHER COSTS A

RESTRUCTURING AND OTHER COSTS Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 38.9	$ 1.2	$ 44.3	$ 2
Dental Consumables, Endodontic and Dental Laboratory Businesses
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	31
Healthcare, Orthodontic and Implant Businesses
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 2.7		$ 7.5

RESTRUCTURING AND OTHER COSTS R

RESTRUCTURING AND OTHER COSTS Restructuring Accruals (Detail) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2015	Jun. 30, 2015
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 9,258	$ 9,258
Restructuring Charges		42,499
Amounts applied		(8,778)
Change in estimates		(679)
Ending Balance		42,300
Employee Severance
Restructuring Reserve [Roll Forward]
Beginning Balance	6,013	6,013
Restructuring Charges		41,470
Amounts applied		(7,261)
Change in estimates		(697)
Ending Balance		39,525
Employee Severance | Restructuring Fiscal 2013 And Prior Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	951	951
Restructuring Charges		81
Amounts applied		(635)
Change in estimates		(76)
Ending Balance		321
Employee Severance | Restructuring Fiscal 2014 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	5,062	5,062
Restructuring Charges		431
Amounts applied		(3,084)
Change in estimates		(74)
Ending Balance		2,335
Employee Severance | Restructuring Fiscal 2015 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	0	0
Restructuring Charges		40,958
Amounts applied		(3,542)
Change in estimates		(547)
Ending Balance		36,869
Contract Termination
Restructuring Reserve [Roll Forward]
Beginning Balance	2,171	2,171
Restructuring Charges		282
Amounts applied		(489)
Change in estimates		(10)
Ending Balance		1,954
Contract Termination | Restructuring Fiscal 2013 And Prior Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	535	535
Restructuring Charges		0
Amounts applied		(105)
Change in estimates		0
Ending Balance		430
Contract Termination | Restructuring Fiscal 2014 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	1,636	1,636
Restructuring Charges		12
Amounts applied		(384)
Change in estimates		(10)
Ending Balance		1,254
Contract Termination | Restructuring Fiscal 2015 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	0	0
Restructuring Charges	270
Amounts applied	0
Change in estimates	0
Ending Balance	270
Other Restructuring
Restructuring Reserve [Roll Forward]
Beginning Balance	1,074	1,074
Restructuring Charges		747
Amounts applied		(1,028)
Change in estimates	(28)
Ending Balance		821
Other Restructuring | Restructuring Fiscal 2013 And Prior Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	25	25
Restructuring Charges		2
Amounts applied		(2)
Change in estimates	0
Ending Balance		25
Other Restructuring | Restructuring Fiscal 2014 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	1,049	1,049
Restructuring Charges		168
Amounts applied		(799)
Change in estimates	(28)
Ending Balance		446
Other Restructuring | Restructuring Fiscal 2015 Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	0	0
Restructuring Charges		577
Amounts applied		(227)
Change in estimates	$ 0
Ending Balance		$ 350

RESTRUCTURING AND OTHER COSTS P

RESTRUCTURING AND OTHER COSTS Provisions and Adjustments and Amounts Applied for All Plans by Segment (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 9,258
Restructuring Charges	42,499
Amounts applied	(8,778)
Change in estimates	(679)
Ending Balance	42,300
Dental Consumables, Endodontic and Dental Laboratory Businesses
Restructuring Reserve [Roll Forward]
Beginning Balance	5,272
Restructuring Charges	31,522
Amounts applied	(3,941)
Change in estimates	0
Ending Balance	32,853
Healthcare, Orthodontic and Implant Businesses
Restructuring Reserve [Roll Forward]
Beginning Balance	3,828
Restructuring Charges	7,517
Amounts applied	(4,558)
Change in estimates	(679)
Ending Balance	6,108
Select Developed and Emerging Markets Businesses
Restructuring Reserve [Roll Forward]
Beginning Balance	91
Restructuring Charges	1,719
Amounts applied	(177)
Change in estimates	0
Ending Balance	1,633
All Other
Restructuring Reserve [Roll Forward]
Beginning Balance	67
Restructuring Charges	1,741
Amounts applied	(102)
Change in estimates	0
Ending Balance	$ 1,706

FINANCIAL INSTRUMENTS AND DER58

FINANCIAL INSTRUMENTS AND DERIVATIVES Cash Flow Hedges (Details) - Jun. 30, 2015 - Cash Flow Hedging - Designated as Hedging Instrument $ in Thousands, SFr in Millions	USD ($)	CHF (SFr)
Derivative [Line Items]
Derivative, Notional Amount	$ 510,582
Derivative, Notional amount maturing within 12 months	255,238
Foreign Exchange Contract
Derivative [Line Items]
Derivative, Notional Amount	337,017
Derivative, Notional amount maturing within 12 months	253,842
Interest Rate Swap
Derivative [Line Items]
Derivative, Notional Amount	172,169	SFr 65
Derivative, Notional amount maturing within 12 months	0
Commodity Contract
Derivative [Line Items]
Derivative, Notional Amount	1,396
Derivative, Notional amount maturing within 12 months	$ 1,396

FINANCIAL INSTRUMENTS AND DER59

FINANCIAL INSTRUMENTS AND DERIVATIVES Gain (Loss) on AOCI - Cash Flow Hedges (Details) - Cash Flow Hedging - Designated as Hedging Instrument - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net	$ (2,362)	$ (4,639)	$ 21,007	$ (3,868)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	5,825	(2,796)	8,780	(5,712)
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	(164)	(162)	159	(69)
Interest Expense | Interest Rate Swap
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net	(58)	(149)	(1,239)	(537)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(1,074)	(929)	(2,040)	(1,856)
Interest Expense | Foreign Exchange Contract
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net		(11)	(8)	(24)
Interest Expense | Commodity Contract
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	(4)
Cost of Sales | Foreign Exchange Contract
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net	(2,069)	(4,636)	22,018	(3,569)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	6,839	(1,651)	10,726	(3,296)
Cost of Sales | Commodity Contract
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net	(96)	101	(96)	203
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(121)	(158)	(250)	(403)
Selling, General and Administrative Expenses | Foreign Exchange Contract
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net	(139)	45	324	35
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	181	(58)	344	(157)
Other Expense | Foreign Exchange Contract
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	$ (160)	$ (151)	$ 167	$ (45)

FINANCIAL INSTRUMENTS AND DER60

FINANCIAL INSTRUMENTS AND DERIVATIVES Net Investment Hedges (Details) - Net Investment Hedging - Designated as Hedging Instrument - Foreign Exchange Contract $ in Thousands	Jun. 30, 2015USD ($)
Derivative [Line Items]
Derivative, Notional Amount	$ 420,892
Derivative, Notional amount maturing within 12 months	$ 236,079

FINANCIAL INSTRUMENTS AND DER61

FINANCIAL INSTRUMENTS AND DERIVATIVES Gain (Loss) on AOCI - Net Investment Hedges (Details) - Designated as Hedging Instrument - Net Investment Hedging - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net	$ (15,819)	$ 2,844	$ (3,320)	$ 1,254
Derivative, Gain (Loss) on Derivative, Net	1,191	217	855	1,683
Cross Currency Basis Swaps Member
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net		1,572		(3,087)
Cross Currency Basis Swaps Member | Interest Income
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		674		1,351
Cross Currency Basis Swaps Member | Interest Expense
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		(384)		157
Cross Currency Basis Swaps Member | Other Expense
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net	1,191	(73)	855	175
Foreign Exchange Contract
Derivative [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net	$ (15,819)	$ 1,272	$ (3,320)	$ 4,341

FINANCIAL INSTRUMENTS AND DER62

FINANCIAL INSTRUMENTS AND DERIVATIVES Fair Value Hedges (Details) - Interest Rate Swap - Designated as Hedging Instrument - Fair Value Hedging - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Derivative [Line Items]
Derivative, Notional Amount	$ 45,000		$ 45,000
Derivative, Notional amount maturing within 12 months	45,000		45,000
Interest Expense
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net	$ 41	$ 133	$ 158	$ 220

FINANCIAL INSTRUMENTS AND DER63

FINANCIAL INSTRUMENTS AND DERIVATIVES Hedges not Designated (Details) - Not Designated as Hedging Instrument - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Derivative [Line Items]
Derivative, Notional Amount		$ 480,551		$ 480,551
Derivative, Notional amount maturing within 12 months		479,143		479,143
Derivative, Gain (Loss) on Derivative, Net		(1,266)	$ (4,647)	6,069	$ (8,502)
Foreign Exchange Forward
Derivative [Line Items]
Derivative, Notional Amount		478,338		478,338
Derivative, Notional amount maturing within 12 months		478,338		478,338
Interest Rate Swap
Derivative [Line Items]
Derivative, Notional Amount		2,213		2,213
Derivative, Notional amount maturing within 12 months		805		805
Other Expense | Foreign Exchange Contract
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net	[1]	(766)	(716)	7,789	(5,157)
Other Expense | Equity Option
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		102	90	107	(138)
Other Expense | Cross Currency Basis Swaps Member
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net	[1]	(603)	(4,005)	(1,825)	(3,180)
Interest Expense | Interest Rate Swap
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		$ 1	$ (16)	$ (2)	$ (27)
[1]	The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances which are recorded in “Other expense (income), net” on the Consolidated Statements of Operations.

FINANCIAL INSTRUMENTS AND DER64

FINANCIAL INSTRUMENTS AND DERIVATIVES Balance Sheet Location (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Prepaid Expenses and Other Current Assets
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 32,722	$ 28,653
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	7,273	7,481
Other Noncurrent Assets
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	2,115	12,677
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Accrued Liabilities
Derivative [Line Items]
Derivative Liability, Fair Value, Gross Liability	2,806	3,548
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	3,516	4,827
Other Noncurrent Liabilities
Derivative [Line Items]
Derivative Liability, Fair Value, Gross Liability	3,417	2,084
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	77	244
Foreign Exchange Forward | Prepaid Expenses and Other Current Assets
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	32,398	28,036
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	7,273	4,798
Foreign Exchange Forward | Other Noncurrent Assets
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	1,833	12,542
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Foreign Exchange Forward | Accrued Liabilities
Derivative [Line Items]
Derivative Liability, Fair Value, Gross Liability	1,490	2,740
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	3,465	4,764
Foreign Exchange Forward | Other Noncurrent Liabilities
Derivative [Line Items]
Derivative Liability, Fair Value, Gross Liability	2,675	1,707
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	0	0
Commodity Contract | Prepaid Expenses and Other Current Assets
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Commodity Contract | Other Noncurrent Assets
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Commodity Contract | Accrued Liabilities
Derivative [Line Items]
Derivative Liability, Fair Value, Gross Liability	152	233
Commodity Contract | Other Noncurrent Liabilities
Derivative [Line Items]
Derivative Liability, Fair Value, Gross Liability	0	0
Interest Rate Swap | Prepaid Expenses and Other Current Assets
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	324	617
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Interest Rate Swap | Other Noncurrent Assets
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	282	135
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Interest Rate Swap | Accrued Liabilities
Derivative [Line Items]
Derivative Liability, Fair Value, Gross Liability	1,164	575
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	51	63
Interest Rate Swap | Other Noncurrent Liabilities
Derivative [Line Items]
Derivative Liability, Fair Value, Gross Liability	742	377
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	$ 77	129
Dio Equity Option Contracts | Prepaid Expenses and Other Current Assets
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value		0
Dio Equity Option Contracts | Other Noncurrent Assets
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value		0
Dio Equity Option Contracts | Accrued Liabilities
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value		0
Dio Equity Option Contracts | Other Noncurrent Liabilities
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value		115
Cross Currency Basis Swaps Member | Prepaid Expenses and Other Current Assets
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value		2,683
Cross Currency Basis Swaps Member | Other Noncurrent Assets
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value		0
Cross Currency Basis Swaps Member | Accrued Liabilities
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value		0
Cross Currency Basis Swaps Member | Other Noncurrent Liabilities
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value		$ 0

FINANCIAL INSTRUMENTS AND DER65

FINANCIAL INSTRUMENTS AND DERIVATIVES Balance Sheet Offsetting (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Derivative Asset [Abstract]
Derivative Asset, Not Subject to Master Netting Arrangement	$ 42,110	$ 48,811
Derivative Asset	42,110	48,811
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Collateral, Obligation to Return Securities	9,536	9,138
Derivative, Collateral, Obligation to Return Cash	0	0
Derivative Asset, Fair Value, Amount Offset Against Collateral	32,574	39,673
Derivative Liability [Abstract]
Derivative Liability, Not Subject to Master Netting Arrangement	9,816	10,703
Derivative Liability	9,816	10,703
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Collateral, Right to Reclaim Securities	(9,536)	(9,138)
Derivative, Collateral, Obligation to Return Cash	0	0
Derivative Liability, Fair Value, Amount Offset Against Collateral	280	1,565
Foreign Exchange Contract
Derivative Asset [Abstract]
Derivative Asset, Not Subject to Master Netting Arrangement	41,504	45,377
Derivative Asset	41,504	45,377
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Collateral, Obligation to Return Securities	9,363	7,797
Derivative, Collateral, Obligation to Return Cash	0	0
Derivative Asset, Fair Value, Amount Offset Against Collateral	32,141	37,580
Derivative Liability [Abstract]
Derivative Liability, Not Subject to Master Netting Arrangement	7,630	9,208
Derivative Liability	7,630	9,208
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Collateral, Right to Reclaim Securities	(7,630)	(8,186)
Derivative, Collateral, Obligation to Return Cash	0	0
Derivative Liability, Fair Value, Amount Offset Against Collateral	0	1,022
Commodity Contract
Derivative Asset [Abstract]
Derivative, Collateral, Obligation to Return Cash	0	0
Derivative Liability [Abstract]
Derivative Liability, Not Subject to Master Netting Arrangement	152	235
Derivative Liability	152	235
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Collateral, Right to Reclaim Securities	0	0
Derivative, Collateral, Obligation to Return Cash	0	0
Derivative Liability, Fair Value, Amount Offset Against Collateral	152	235
Dio Equity Option Contracts
Derivative Asset [Abstract]
Derivative, Collateral, Obligation to Return Cash		0
Derivative Liability [Abstract]
Derivative Liability, Not Subject to Master Netting Arrangement		115
Derivative Liability		115
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Collateral, Right to Reclaim Securities		0
Derivative, Collateral, Obligation to Return Cash		0
Derivative Liability, Fair Value, Amount Offset Against Collateral		115
Interest Rate Swap
Derivative Asset [Abstract]
Derivative Asset, Not Subject to Master Netting Arrangement	606	751
Derivative Asset	606	751
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Collateral, Obligation to Return Securities	173	274
Derivative, Collateral, Obligation to Return Cash	0	0
Derivative Asset, Fair Value, Amount Offset Against Collateral	433	477
Derivative Liability [Abstract]
Derivative Liability, Not Subject to Master Netting Arrangement	2,034	1,145
Derivative Liability	2,034	1,145
Derivative Liability, Securities Sold under Agreements to Resell, Securities Loaned, Collateral, Right to Reclaim Securities	(1,906)	(952)
Derivative, Collateral, Obligation to Return Cash	0	0
Derivative Liability, Fair Value, Amount Offset Against Collateral	$ 128	193
Cross Currency Basis Swaps Member
Derivative Asset [Abstract]
Derivative Asset, Not Subject to Master Netting Arrangement		2,683
Derivative Asset		2,683
Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed, Collateral, Obligation to Return Securities		1,067
Derivative, Collateral, Obligation to Return Cash		0
Derivative Asset, Fair Value, Amount Offset Against Collateral		1,616
Derivative Liability [Abstract]
Derivative, Collateral, Obligation to Return Cash		$ 0

FINANCIAL INSTRUMENTS AND DER66

FINANCIAL INSTRUMENTS AND DERIVATIVES Additional Information (Details) - group	3 Months Ended	6 Months Ended
	Mar. 31, 2015	Jun. 30, 2015
Derivative [Line Items]
Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge	18 months
Number of groups of significant interest rate swaps	2
Fair Value Hedging | Private Placement Notes Member
Derivative [Line Items]
Debt Instrument Maturity Period	5 years
Interest Rate Swap | Fair Value Hedging | Private Placement Notes Member
Derivative [Line Items]
Derivative, Term of Contract		5 years
Currency Japanese Yen Member | Interest Rate Swap
Derivative [Line Items]
Derivative, Term of Contract	5 years
Currency Swiss Franc Member | Interest Rate Swap
Derivative [Line Items]
Derivative, Term of Contract	5 years

FINANCIAL INSTRUMENTS AND DER67

FINANCIAL INSTRUMENTS AND DERIVATIVES - Narrative (Details) SFr in Millions, ¥ in Billions	6 Months Ended
	Jun. 30, 2015USD ($)	Jun. 30, 2015CHF (SFr)	Jun. 30, 2015JPY (¥)	Apr. 04, 2011USD ($)	Feb. 28, 2010USD ($)
Term Loan Agreement
Derivative [Line Items]
Derivative, Notional Amount | ¥			¥ 12.6
Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Notional Amount	$ 480,551,000
Interest Rate Swap | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Notional Amount	2,213,000
Cross Currency Basis Swaps Member | Designated as Hedging Instrument
Derivative [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	9,600,000
Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Notional Amount	$ 510,582,000
Cash Flow Hedging | Interest Rate Swap | Term Loan Agreement
Derivative [Line Items]
Derivative, Fixed Interest Rate	0.90%	0.90%	0.90%
Cash Flow Hedging | Interest Rate Swap | Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Fixed Interest Rate	0.70%	0.70%	0.70%
Derivative, Notional Amount	$ 172,169,000	SFr 65
Fair Value Hedging | Interest Rate Swap | Private Placement Notes Member
Derivative [Line Items]
Derivative, Fixed Interest Rate				4.10%
Derivative, Notional Amount				$ 150,000,000
Debt Instrument, Face Amount					$ 250,000,000
Derivative, Term of Contract	5 years
Fair Value Hedging | Interest Rate Swap | Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Notional Amount	$ 45,000,000

FAIR VALUE MEASUREMENT Financia

FAIR VALUE MEASUREMENT Financial Assets and Liabilities that are Recorded at Fair Value and Classified Based on the Lowest Level of Input (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	$ 195,723	$ 106,509
Liabilities	55,142	116,726
Interest Rate Swap
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	606	752
Liabilities	2,034	1,144
Commodity Contract
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	152	233
Cross Currency Interest Rate Swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets		2,683
Foreign Exchange Forward
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	41,504	45,376
Liabilities	7,630	9,211
Corporate Bond Securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	153,613	57,698
Long-term Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	45,326	106,023
Dio Equity Option Contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities		115
Fair Value, Inputs, Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Liabilities	0	0
Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	42,110	48,811
Liabilities	55,142	116,611
Fair Value, Inputs, Level 2 | Interest Rate Swap
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	606	752
Liabilities	2,034	1,144
Fair Value, Inputs, Level 2 | Commodity Contract
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	152	233
Fair Value, Inputs, Level 2 | Cross Currency Interest Rate Swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets		2,683
Fair Value, Inputs, Level 2 | Foreign Exchange Forward
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	41,504	45,376
Liabilities	7,630	9,211
Fair Value, Inputs, Level 2 | Long-term Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	45,326	106,023
Fair Value, Inputs, Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	153,613	57,698
Liabilities	0	115
Fair Value, Inputs, Level 3 | Corporate Bond Securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	$ 153,613	57,698
Fair Value, Inputs, Level 3 | Dio Equity Option Contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities		$ 115

FAIR VALUE MEASUREMENT Reconcil

FAIR VALUE MEASUREMENT Reconciliation Assets Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2015USD ($)
Corporate Bond Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	$ 57,698
Unrealized Loss Reported in AOCI	101,351
Effect of exchange rate changes	(5,436)
Ending Balance	153,613
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Unrealized Loss Reported in AOCI	101,351
Effect of exchange rate changes	(5,436)
Dio Equity Option Contracts
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unobservable Input, Unrealized Gain (Loss)	107
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Unrealized Loss Reported in AOCI	0
Effect of exchange rate changes	8
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance	(115)
Unrealized Loss Reported in AOCI	0
Effect of exchange rate changes	8
Ending Balance	$ 0

FAIR VALUE MEASUREMENT Addition

FAIR VALUE MEASUREMENT Additional Information (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Corporate Bond Securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Approximate stock volatility	40.00%
Discount rate	8.70%
Fixed rate senior notes $450 million due August 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt, fixed rate	4.10%
Tranche C | Unsecured Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	$ 450,000,000
Tranche B | Unsecured Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	300,000,000
Tranche A | Unsecured Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	$ 250,000,000
Private Placement Notes Member | U.S. Dollar Denominated Expiring March 2016
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt, fixed rate	4.10%
Fixed Rate Senior Notes | U.S. Dollar Denominated Due August 2016
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt, fixed rate	2.80%
Estimate of Fair Value, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term Debt, Fair Value	$ 1,195,300,000	$ 1,286,200,000
Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term Debt, Fair Value	$ 1,161,500,000	$ 1,258,900,000

INCOME TAXES Additional Informa

INCOME TAXES Additional Information (Detail) - Jun. 30, 2015 - USD ($) $ in Millions	Total
Income Taxes [Line Items]
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount	$ 3.1
Future Period Member
Income Taxes [Line Items]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit	2.2
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	0.9
Unrecognized tax benefits, expiration of statues of limitation	$ 0.4

FINANCING ARRANGEMENTS Long-Ter

FINANCING ARRANGEMENTS Long-Term Borrowings (Detail) - USD ($)	3 Months Ended	6 Months Ended
	Mar. 31, 2015	Jun. 30, 2015	Jun. 30, 2014	Jul. 01, 2015	Jul. 24, 2014
Debt Instrument [Line Items]
Long-term Debt		$ 100,232,000	$ 75,371,000
Line of Credit Facility, Remaining Borrowing Capacity		526,000,000
Commercial Paper
Debt Instrument [Line Items]
Long-term Debt	$ 100,000,000
Private Placement
Debt Instrument [Line Items]
Short-term Debt		75,000,000
Revolving Credit Agreement
Debt Instrument [Line Items]
Long-term Line of Credit		30,000,000
Line of Credit Facility, Maximum Borrowing Capacity					$ 500,000,000
Term Loan Agreement
Debt Instrument [Line Items]
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months		$ 8,800,000
Subsequent Event [Member] | Revolving Credit Agreement | Credit Facility Agreement Through 2019
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity				$ 500,000,000
Subsequent Event [Member] | Revolving Credit Agreement | Credit Facility Agreement Through 2020
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity				$ 452,000,000

GOODWILL AND INTANGIBLE ASSET73

GOODWILL AND INTANGIBLE ASSETS Reconciliation of Changes in Goodwill (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2015USD ($)
Goodwill [Roll Forward]
Balance, beginning of the year	$ 2,089,339
Goodwill, Translation Adjustments	(90,731)
Balance, end of the year	1,998,608
Dental Consumables, Endodontic and Dental Laboratory Businesses
Goodwill [Roll Forward]
Balance, beginning of the year	565,714
Goodwill, Translation Adjustments	(6,268)
Balance, end of the year	559,446
Healthcare, Orthodontic and Implant Businesses
Goodwill [Roll Forward]
Balance, beginning of the year	1,394,398
Goodwill, Translation Adjustments	(76,509)
Balance, end of the year	1,317,889
Select Developed and Emerging Markets Businesses
Goodwill [Roll Forward]
Balance, beginning of the year	129,227
Goodwill, Translation Adjustments	(7,954)
Balance, end of the year	$ 121,273

GOODWILL AND INTANGIBLE ASSET74

GOODWILL AND INTANGIBLE ASSETS Identifiable Definite-Lived Intangible Assets (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 701,584	$ 738,351
Accumulated Amortization	(266,877)	(260,088)
Net Carrying Amount	434,707	478,263
Identifiable Intangible Assets Gross	883,546	930,928
Intangible Assets, Net (Excluding Goodwill)	616,669	670,840
In-process research and development
Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	181,962	192,577
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	165,615	175,186
Accumulated Amortization	(91,135)	(95,526)
Net Carrying Amount	74,480	79,660
In-process research and development
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	68,271	75,645
Accumulated Amortization	(38,027)	(37,053)
Net Carrying Amount	30,244	38,592
Licensing Agreements
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	34,071	34,638
Accumulated Amortization	(23,629)	(22,806)
Net Carrying Amount	10,442	11,832
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	433,627	452,882
Accumulated Amortization	(114,086)	(104,703)
Net Carrying Amount	$ 319,541	$ 348,179

GOODWILL AND INTANGIBLE ASSET75

GOODWILL AND INTANGIBLE ASSETS Intangible Assets Impairment (Details) $ in Millions	6 Months Ended
	Jun. 30, 2015USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Impairment of Intangible Assets (Excluding Goodwill)	$ 4

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail)	1 Months Ended
	Jan. 31, 2014	Dec. 31, 2006	Jun. 30, 2004
San Francisco County California Member
Commitments and Contingencies Disclosure [Line Items]
Loss Contingency, Trial or Alternative Dispute Resolution			On June 18, 2004, Marvin Weinstat, DDS and Richard Nathan, DDS filed a class action suit in San Francisco County, California alleging that the Company misrepresented that its Cavitron® ultrasonic scalers are suitable for use in oral surgical procedures.
Loss Contingency, Lawsuit Filing Date			June 18, 2004
Loss Contingency, Name of Plaintiff			Marvin Weinstat, DDS and Richard Nathan, DDS
Eastern District Of Pennsylvania Member
Commitments and Contingencies Disclosure [Line Items]
Loss Contingency, Trial or Alternative Dispute Resolution	On January 20, 2014, the Company was served with a qui tam complaint filed by two former and one current employee of the Company under the Federal False Claims Act and equivalent state and city laws. The lawsuit was previously under seal in the U.S. District Court for the Eastern District of Pennsylvania	On December 12, 2006, a Complaint was filed by Carole Hildebrand, DDS and Robert Jaffin, DDS in the Eastern District of Pennsylvania (the Plaintiffs subsequently added Dr. Mitchell Goldman as a named class representative).  The case was filed by the same law firm that filed the Weinstat case in California.  The Complaint asserts putative class action claims on behalf of dentists located in New Jersey and Pennsylvania.
Loss Contingency, Lawsuit Filing Date	Jan. 20, 2014	December 12, 2006
Loss Contingency, Name of Plaintiff	Former and Current Employees	Carole Hildebrand, DDS and Robert Jaffin, DDS and Dr. Mitchell Goldman

Uncategorized Items - xray-2015

Label	Element	Value
Parent [Member]
Dividends, Cash	us-gaap_DividendsCash	$ 20,275